JP2001323125A - Cholesteric liquid crystal composition, oriented film and multicolor reflective plate - Google Patents
Cholesteric liquid crystal composition, oriented film and multicolor reflective plateInfo
- Publication number
- JP2001323125A JP2001323125A JP2000147230A JP2000147230A JP2001323125A JP 2001323125 A JP2001323125 A JP 2001323125A JP 2000147230 A JP2000147230 A JP 2000147230A JP 2000147230 A JP2000147230 A JP 2000147230A JP 2001323125 A JP2001323125 A JP 2001323125A
- Authority
- JP
- Japan
- Prior art keywords
- group
- liquid crystal
- crystal composition
- cholesteric liquid
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 title claims abstract description 58
- 239000000178 monomer Substances 0.000 claims abstract description 81
- 229920000106 Liquid crystal polymer Polymers 0.000 claims abstract description 59
- 239000004988 Nematic liquid crystal Substances 0.000 claims abstract description 52
- 230000003098 cholesteric effect Effects 0.000 claims abstract description 22
- 238000004132 cross linking Methods 0.000 claims description 38
- 238000011282 treatment Methods 0.000 claims description 38
- 238000004519 manufacturing process Methods 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 25
- 125000004122 cyclic group Chemical group 0.000 claims description 15
- 125000000524 functional group Chemical group 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 2
- 244000105975 Antidesma platyphyllum Species 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000006267 biphenyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 235000009424 haa Nutrition 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 78
- 239000004973 liquid crystal related substance Substances 0.000 description 64
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 51
- 239000000243 solution Substances 0.000 description 46
- 239000010408 film Substances 0.000 description 41
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 30
- 239000002904 solvent Substances 0.000 description 26
- 239000000126 substance Substances 0.000 description 25
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
- 238000003756 stirring Methods 0.000 description 21
- -1 tetrahydrobenzyl group Chemical group 0.000 description 20
- 230000015572 biosynthetic process Effects 0.000 description 17
- 238000010438 heat treatment Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 14
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 229920006395 saturated elastomer Polymers 0.000 description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 8
- 239000002262 Schiff base Substances 0.000 description 8
- 150000004753 Schiff bases Chemical class 0.000 description 8
- 238000010894 electron beam technology Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000012046 mixed solvent Substances 0.000 description 8
- UBHQPRAAGGFDID-UHFFFAOYSA-N 4-(2-prop-2-enoyloxyethoxy)benzoic acid Chemical compound OC(=O)C1=CC=C(OCCOC(=O)C=C)C=C1 UBHQPRAAGGFDID-UHFFFAOYSA-N 0.000 description 7
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 239000003999 initiator Substances 0.000 description 7
- 229960002479 isosorbide Drugs 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000007334 copolymerization reaction Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000012788 optical film Substances 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 3
- FOQJFNDGCQAUCE-UHFFFAOYSA-N 4-methoxycarbonyloxybenzoic acid Chemical compound COC(=O)OC1=CC=C(C(O)=O)C=C1 FOQJFNDGCQAUCE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 230000009477 glass transition Effects 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000003918 triazines Chemical class 0.000 description 3
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 2
- QLIQIXIBZLTPGQ-UHFFFAOYSA-N 4-(2-hydroxyethoxy)benzoic acid Chemical compound OCCOC1=CC=C(C(O)=O)C=C1 QLIQIXIBZLTPGQ-UHFFFAOYSA-N 0.000 description 2
- ZRMIETZFPZGBEB-UHFFFAOYSA-N 4-(4-hydroxyphenyl)benzonitrile Chemical group C1=CC(O)=CC=C1C1=CC=C(C#N)C=C1 ZRMIETZFPZGBEB-UHFFFAOYSA-N 0.000 description 2
- ADCUEPOHPCPMCE-UHFFFAOYSA-N 4-cyanobenzoic acid Chemical compound OC(=O)C1=CC=C(C#N)C=C1 ADCUEPOHPCPMCE-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- FWUAQGBTYHNQBJ-UHFFFAOYSA-N C1CC=CC(C1)COC(=O)C2=CC=C(C=C2)O Chemical compound C1CC=CC(C1)COC(=O)C2=CC=C(C=C2)O FWUAQGBTYHNQBJ-UHFFFAOYSA-N 0.000 description 2
- XGPXQYMQKGIFCS-UHFFFAOYSA-N C1CC=CC(C1)COC(=O)C2=CC=C(C=C2)OC(=O)C3=CC=C(C=C3)O Chemical compound C1CC=CC(C1)COC(=O)C2=CC=C(C=C2)OC(=O)C3=CC=C(C=C3)O XGPXQYMQKGIFCS-UHFFFAOYSA-N 0.000 description 2
- KAAKOJLFVRIJIY-UHFFFAOYSA-N COC(=O)OC1=CC=C(C=C1)C(=O)OCC2CCCC=C2 Chemical compound COC(=O)OC1=CC=C(C=C1)C(=O)OCC2CCCC=C2 KAAKOJLFVRIJIY-UHFFFAOYSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- VEIYJWQZNGASMA-UHFFFAOYSA-N cyclohex-3-en-1-ylmethanol Chemical compound OCC1CCC=CC1 VEIYJWQZNGASMA-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- OKZSNEDUVVLIRB-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1OCCOC(=O)C=C OKZSNEDUVVLIRB-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- UHFFVFAKEGKNAQ-UHFFFAOYSA-N 2-benzyl-2-(dimethylamino)-1-(4-morpholin-4-ylphenyl)butan-1-one Chemical compound C=1C=C(N2CCOCC2)C=CC=1C(=O)C(CC)(N(C)C)CC1=CC=CC=C1 UHFFVFAKEGKNAQ-UHFFFAOYSA-N 0.000 description 1
- JTGCXYYDAVPSFD-UHFFFAOYSA-N 4-(4-hydroxyphenyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(O)C=C1 JTGCXYYDAVPSFD-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- DIVDMRQLKAHCCV-UHFFFAOYSA-N COC(=O)OC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C(=O)OCC3CCCC=C3 Chemical compound COC(=O)OC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C(=O)OCC3CCCC=C3 DIVDMRQLKAHCCV-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- WBNZLLXHRQYGBM-UHFFFAOYSA-N ClC(N1NC(=CC(=N1)C(Cl)(Cl)Cl)C1=CC(=C(C=C1)OC)OC)(Cl)Cl Chemical compound ClC(N1NC(=CC(=N1)C(Cl)(Cl)Cl)C1=CC(=C(C=C1)OC)OC)(Cl)Cl WBNZLLXHRQYGBM-UHFFFAOYSA-N 0.000 description 1
- OLVZVRJOZLIWLZ-UHFFFAOYSA-N ClC(N1NC(=CC(=N1)C(Cl)(Cl)Cl)C1=CC=C(C2=CC=CC=C12)OC)(Cl)Cl Chemical compound ClC(N1NC(=CC(=N1)C(Cl)(Cl)Cl)C1=CC=C(C2=CC=CC=C12)OC)(Cl)Cl OLVZVRJOZLIWLZ-UHFFFAOYSA-N 0.000 description 1
- 101001034314 Homo sapiens Lactadherin Proteins 0.000 description 1
- 102100039648 Lactadherin Human genes 0.000 description 1
- 239000004976 Lyotropic liquid crystal Substances 0.000 description 1
- 101100219325 Phaseolus vulgaris BA13 gene Proteins 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- VCCBEIPGXKNHFW-UHFFFAOYSA-N biphenyl-4,4'-diol Chemical compound C1=CC(O)=CC=C1C1=CC=C(O)C=C1 VCCBEIPGXKNHFW-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000004643 cyanate ester Substances 0.000 description 1
- 150000001913 cyanates Chemical class 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- BLCTWBJQROOONQ-UHFFFAOYSA-N ethenyl prop-2-enoate Chemical compound C=COC(=O)C=C BLCTWBJQROOONQ-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 230000002535 lyotropic effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002794 monomerizing effect Effects 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Optical Filters (AREA)
- Polarising Elements (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Liquid Crystal (AREA)
- Liquid Crystal Substances (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、コレステリック性
液晶組成物、配向フィルムおよび多色反射板に関する。
本発明のコレステリック性液晶組成物は、配向架橋処理
されてモノドメイン配向フィルムとなり各種光学フィル
ム等に用いうる。特に、配向フィルムの調製にあたっ
て、光学活性基の含有量を制御したモノドメイン配向フ
ィルムは、多色反射板として有用である。The present invention relates to a cholesteric liquid crystal composition, an alignment film, and a multicolor reflector.
The cholesteric liquid crystal composition of the present invention is subjected to orientation crosslinking treatment to form a monodomain oriented film, which can be used for various optical films and the like. In particular, when preparing an oriented film, a monodomain oriented film in which the content of an optically active group is controlled is useful as a multicolor reflector.
【0002】[0002]
【従来の技術】反射型液晶表示装置は、透過型液晶表示
装置と比較するとバックライトが不要であるという大き
な特徴を有するため、当該表示装置を薄く、軽くするこ
とが可能であり、しかもバックライトに必要な消費電力
を削減することができる。かかる特徴は、液晶表示装置
を備え、電源の容量が限られた携帯用の機器類、とりわ
け携帯用のノートパソコンの表示装置としての利用価値
が大きい。2. Description of the Related Art A reflection type liquid crystal display device has a great feature that a backlight is not required as compared with a transmission type liquid crystal display device. Therefore, the display device can be made thinner and lighter. Required power consumption can be reduced. This feature has great utility as a portable device having a liquid crystal display device and a limited power supply capacity, particularly as a display device for a portable notebook personal computer.
【0003】この反射型表示装置においては、透過型液
晶表示装置に準じてカラー表示化を達成することが要求
されている。これまでは反射型表示装置においても透過
型液晶表示装置で使用されているカラーフィルターを用
いたカラー化技術が採用されていた。しかし、かかるカ
ラー化技術を用いた反射型液晶表示装置は表示が暗く、
視認性に乏しいものであることから、別個のカラー化技
術が求められている。In the reflection type display device, it is required to achieve color display in accordance with the transmission type liquid crystal display device. Heretofore, a color display technology using a color filter used in a transmissive liquid crystal display device has also been employed in a reflective display device. However, the reflection type liquid crystal display device using such a color technology has a dark display,
Because of poor visibility, a separate color technology is required.
【0004】このような反射型液晶表示装置における新
たなカラー化技術としては、液晶の複屈折による着色変
化(ECBモード)を利用したものが提案されている。
しかしながら、このカラー化技術は、表示色やその色数
が限定されていて、多色カラー性に乏しく、また色純度
にも劣って鮮明性に乏しい難点があった。As a new color technology for such a reflection type liquid crystal display device, a technology utilizing color change (ECB mode) due to birefringence of liquid crystal has been proposed.
However, this colorization technique has a drawback in that the display colors and the number of colors are limited, the multicolor color is poor, and the color purity is poor and the sharpness is poor.
【0005】一方、低分子量の液状コレステリック性液
晶による選択反射性を利用したカラー化技術も提案され
ている(J.Phys.D:Appl .Phys.,v
ol.8,1441;1975)。しかしながら、この
カラー化技術では、液状の液晶を用いるため、液晶表示
装置が、液晶をガラス基板間等に挟持した構造となって
重くて厚いものとなり、反射型の液晶表示装置には不向
きであると共に、液晶の流動性が色区画の固定性を低下
させ、また熱により色特性が変化しやすいという問題が
あった。On the other hand, a coloring technique utilizing selective reflection by a low-molecular-weight liquid cholesteric liquid crystal has also been proposed (J. Phys. D: Appl. Phys., V.
ol. 8, 1441; 1975). However, in this color technology, since a liquid crystal is used, the liquid crystal display device has a structure in which the liquid crystal is sandwiched between glass substrates or the like, and is heavy and thick, which is not suitable for a reflection type liquid crystal display device. At the same time, there is a problem that the fluidity of the liquid crystal lowers the fixation of the color sections, and the color characteristics are easily changed by heat.
【0006】他方、リオトロピック型の液晶ポリマーを
モノマーに溶解させて、それを温度制御下に活性光線を
使用して重合固定化したフィルムも提案されている(特
開昭59−83113号公報)。しかしながら、この技
術では、色制御を温度によって行う必要があること、ま
た液晶ポリマーがリオトロピック性のためにフィルム形
成時に基板挟持構造とすることが必要であること等のた
め、赤色領域、緑色領域、青色領域等の色区画を微細化
することが困難であると共に大面積化や量産化も困難で
あった。On the other hand, there has been proposed a film obtained by dissolving a lyotropic liquid crystal polymer in a monomer and polymerizing and fixing the same using actinic rays under temperature control (JP-A-59-83113). However, in this technology, it is necessary to perform color control by temperature, and it is necessary that the liquid crystal polymer has a substrate sandwiching structure at the time of film formation for lyotropic properties. It is difficult to reduce the size of a color section such as a blue region, and it is also difficult to increase the area and mass production.
【0007】上記の問題を解消すべく、特開平10−5
4905号公報には、シッフ塩基を有するコレステリッ
ク性液晶ポリマーに光酸発生剤を添加し、紫外線等の活
性光線の照射にて発生した酸により、シッフ塩基を切断
等してコレステリック性液晶ポリマーの面内でのコレス
テリックピッチを制御した多色反射板、並びにその製造
方法が提案されている。この技術は、表示色や色数の制
御が容易で色純度に優れ、反射型液晶表示装置における
鮮明で豊富な多色カラーによる良視認性の表示が達成で
き、しかも軽くて薄く、色区画の固定性に優れ、色特性
が実用温度で変化しにくい光学素子を製造することがで
きる。In order to solve the above problem, Japanese Patent Application Laid-Open No. H10-5
No. 4905 discloses that a photoacid generator is added to a cholesteric liquid crystal polymer having a Schiff base, and the acid generated by irradiation with actinic rays such as ultraviolet rays is used to cut off the Schiff base or the like to obtain a surface of the cholesteric liquid crystal polymer. There has been proposed a multicolor reflector in which the cholesteric pitch in the inside is controlled, and a method of manufacturing the same. This technology is easy to control the display colors and the number of colors, has excellent color purity, and can achieve good visibility display with clear and abundant multi-colors in the reflection type liquid crystal display device. It is possible to manufacture an optical element having excellent fixation properties and in which color characteristics do not easily change at a practical temperature.
【0008】しかしながら、上記多色化処理工程によ
り、光学活性基の含有量を調整してコレステリック性液
晶ポリマーの面内でのコレステリックピッチを制御し
て、十分な選択反射色を達成するためには、コレステリ
ック性液晶ポリマーがシッフ塩基などの結合基を有する
ことが不可欠ではあるものの、シッフ塩基などの結合基
を有するコレステリック性液晶ポリマーは、加熱配向時
における熱的安定性等の性質が十分でないため、多色反
射板における一定の品質を保持することが難しい。However, in order to achieve a sufficient selective reflection color by controlling the cholesteric pitch in the plane of the cholesteric liquid crystal polymer by adjusting the content of the optically active group by the above-mentioned multicoloring treatment step. Although it is essential that the cholesteric liquid crystal polymer has a binding group such as a Schiff base, the cholesteric liquid crystal polymer having a binding group such as a Schiff base has insufficient properties such as thermal stability at the time of heating alignment. However, it is difficult to maintain a constant quality in the multicolor reflector.
【0009】[0009]
【発明が解決しようとする課題】そこで、本発明は、耐
熱性に優れ、しかも多色反射板等に利用できるモノドメ
イン配向フィルムを形成しうるコレステリック性液晶組
成物を提供することを目的とする。SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a cholesteric liquid crystal composition having excellent heat resistance and capable of forming a monodomain oriented film usable for a multicolor reflector or the like. .
【0010】[0010]
【課題を解決するための手段】本発明者らは、上記課題
を解決すべく、鋭意研究した結果、以下に示すコレステ
リック性液晶組成物により、前記目的を達成できること
を見出し、本発明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, have found that the above-mentioned object can be achieved by the cholesteric liquid crystal composition shown below, thereby completing the present invention. Reached.
【0011】すなわち、本発明は、一般式(a1):That is, the present invention provides a compound represented by the general formula (a1):
【化10】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xは−COO−
基、−OCO−基または−O−基を、Eはシアノ基、ア
ルキル基、アルコキシ基、ヒドロキシ基、塩素原子また
はフッ素原子を、gは2〜6の整数を示す。)で表され
る繰り返し単位、および、一般式(a2):Embedded image (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group, and X represents -COO-
A group, —OCO— or —O—, E represents a cyano group, an alkyl group, an alkoxy group, a hydroxy group, a chlorine atom or a fluorine atom, and g represents an integer of 2 to 6. And a repeating unit represented by general formula (a2):
【化11】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xはそれぞれ独立
して−COO−基、−OCO−基または−O−基を、G
は架橋基を、hは2〜6の整数を、kは0〜6の整数を
示す。)で表される繰り返し単位を有する架橋型ネマチ
ック性液晶ポリマー(a)、一般式(b1):Embedded image (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group; X each independently represents a -COO- group, -OCO- group or -O- group;
Represents a crosslinking group, h represents an integer of 2 to 6, and k represents an integer of 0 to 6. A) a cross-linked nematic liquid crystal polymer having a repeating unit represented by formula (a), and a general formula (b1):
【化12】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xはそれぞれ独立
して−COO−基、−OCO−基または−O−基を、L
は活性光線により変性ないし失活しない光学活性基を、
Eはシアノ基、アルキル基、アルコキシ基、ヒドロキシ
基、塩素原子またはフッ素原子を、rは2〜6の整数を
示す。)で表される繰り返し単位、および、一般式(b
2):Embedded image (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group; X each independently represents a -COO- group, -OCO- group or -O- group;
Is an optically active group that is not modified or deactivated by actinic light,
E represents a cyano group, an alkyl group, an alkoxy group, a hydroxy group, a chlorine atom or a fluorine atom, and r represents an integer of 2 to 6. ) And a general formula (b)
2):
【化13】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xはそれぞれ独立
して−COO−基、−OCO−基または−O−基を、G
は架橋基を、hは2〜6の整数を、kは0〜6の整数を
示す。)で表される繰り返し単位を有する架橋型コレス
テリック性液晶ポリマー(b)、ならびに、一般式
(c):Embedded image (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group; X each independently represents a -COO- group, -OCO- group or -O- group;
Represents a crosslinking group, h represents an integer of 2 to 6, and k represents an integer of 0 to 6. A) a cross-linked cholesteric liquid crystal polymer (b) having a repeating unit represented by:
【化14】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xは−COO−
基、−OCO−基または−O−基を、Jは活性光線によ
り変性ないし失活する光学活性基を、wは2〜6の整数
を示す。)で表されるコレステリック性を付与するモノ
マー(c)を含有してなるコレステリック性液晶組成
物、に関する。Embedded image (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group, and X represents -COO-
A group, -OCO- group or -O- group, J represents an optically active group which is modified or deactivated by actinic rays, and w represents an integer of 2 to 6. The present invention relates to a cholesteric liquid crystal composition containing a monomer (c) for imparting cholesteric properties represented by the formula (1).
【0012】前記本発明の液晶組成物は、ネマチック性
液晶ポリマー(a)が架橋型であることに加え、コレス
テリック性液晶ポリマー(b)も架橋型であり、配向後
における後架橋によって、液晶性を維持した架橋形態の
液晶ポリマーが得られることから、耐熱性が向上するた
め熱的安定性がよい。In the liquid crystal composition of the present invention, in addition to the nematic liquid crystal polymer (a) being cross-linked, the cholesteric liquid crystal polymer (b) is also cross-linked. Since a cross-linked liquid crystal polymer maintaining the above is obtained, heat resistance is improved and thermal stability is good.
【0013】また、前記架橋型コレステリック性液晶ポ
リマー(b)の光学活性基(L)は活性光線に対し安定
なものであり、一方、コレステリック性を付与するモノ
マー(c)の光学活性基(J)は活性光線に対し活性で
不安定なものである。このように本発明の液晶組成物
は、活性光線に対する安定性の異なる光学活性基によっ
て、選択反射特性に関わる光学活性基の有効成分含有量
の制御が可能であり、多色反射板等に利用できるモノド
メイン配向フィルムを形成しうる。なお、前記一般式
(b)および一般式(c)中の光学活性基に係わる変性
ないし失活とは、光学活性基の結合基の切断や構造変
化、異性化や転移などにより光学活性基がグランジャン
配向における螺旋ピッチの形成に有効に寄与しない状態
となることを意味する。The optically active group (L) of the crosslinked cholesteric liquid crystal polymer (b) is stable to actinic rays, while the optically active group (J) of the monomer (c) imparting cholestericity is active. ) Are active and unstable to actinic rays. As described above, the liquid crystal composition of the present invention can control the effective component content of the optically active group relating to the selective reflection property by the optically active group having different stability to actinic rays, and is used for a multicolor reflector and the like. The resulting monodomain oriented film can be formed. The modification or deactivation of the optically active group in the general formulas (b) and (c) means that the optically active group is changed due to cleavage of the bonding group of the optically active group, structural change, isomerization, transition or the like. This means that the state does not effectively contribute to the formation of the helical pitch in the Grandian orientation.
【0014】かかる本発明のコレステリック性液晶組成
物は、たとえば、ガラス転移温度以上に加熱後冷却する
方式にて配向処理でき、常法により架橋処理することに
より液晶ポリマー化できる。したがって、従来のコレス
テリック性液晶組成物に準じ、低温で配向架橋処理によ
り、耐熱性に優れる配向フィルムの大面積体も容易に効
率よく製造することができる。また、本発明の液晶組成
物、配向フィルムは、活性光線に対し活性で不安定な光
学活性基の割合が制御されているため、雰囲気中や溶媒
中の酸性不純物に対する安定性、溶液安定性にも優れ
る。The cholesteric liquid crystal composition of the present invention can be subjected to an alignment treatment by, for example, a method of heating to a temperature equal to or higher than the glass transition temperature and then cooling, and can be converted into a liquid crystal polymer by a crosslinking treatment in a conventional manner. Therefore, according to the conventional cholesteric liquid crystal composition, a large area body of an oriented film having excellent heat resistance can be easily and efficiently produced by the orientation crosslinking treatment at a low temperature. In addition, the liquid crystal composition and the alignment film of the present invention are controlled in the ratio of optically active groups that are active and unstable to actinic rays, so that the stability to acidic impurities in the atmosphere and the solvent and the solution stability are improved. Is also excellent.
【0015】前記一般式(a1)、一般式(a2)、一
般式(b1)、一般式(b2)、一般式(c)において
AおよびDは環状系官能基であれば特に制限されない
が、コレステリック性液晶組成物の配向性を考慮する
と、環状系官能基としては、下記一般式、In the general formulas (a1), (a2), (b1), (b2) and (c), A and D are not particularly limited as long as they are cyclic functional groups. Considering the orientation of the cholesteric liquid crystal composition, as the cyclic functional group, the following general formula,
【化15】 で表される環状系官能基のいずれかであることが好まし
い。Embedded image It is preferably any of the cyclic functional groups represented by
【0016】また、一般式(a2)、一般式(b2)に
おいてGは架橋基であれば特に制限されないが、常態に
おいて比較的安定性が高く、また従来の架橋処理で比較
的容易に解裂し架橋反応を起こしうるの点で、下記一般
式、In the general formulas (a2) and (b2), G is not particularly limited as long as it is a cross-linking group, but has a relatively high stability under normal conditions and is relatively easily cleaved by a conventional cross-linking treatment. In that a cross-linking reaction can occur, the following general formula:
【化16】 (式中、R1 は水素原子またはメチル基を示す)で表さ
れる架橋基のいずれかであることが好ましい。これら架
橋基のなかでも、脂環系の架橋基が、ポリマーの重合時
に架橋するおそれがないため合成が容易な点で好まし
い。Embedded image (Wherein, R 1 represents a hydrogen atom or a methyl group). Among these crosslinking groups, alicyclic crosslinking groups are preferred because they have no risk of crosslinking at the time of polymerizing the polymer and are easy to synthesize.
【0017】また、前記一般式(b1)におけるL(活
性光線により変性ないし失活しない光学活性基)は、一
般式、L (an optically active group which is not modified or deactivated by actinic rays) in the general formula (b1) is represented by the general formula:
【化17】 (各式中、t,uは、0≦t≦5、1≦u≦6、かつt
+1≦uを満足する整数を示す。)で表される光学活性
基(l)のいずれかであることが好ましい。このような
光学活性基(l)は、活性光線に対して活性なシッフ塩
基等の連結基を含まず、溶液安定性や配向時の熱的安定
性に優れ、耐熱性が向上する。Embedded image (In each formula, t and u are 0 ≦ t ≦ 5, 1 ≦ u ≦ 6, and t
Indicates an integer satisfying + 1 ≦ u. )) Is preferable. Such an optically active group (1) does not contain a linking group such as a Schiff base that is active with respect to actinic rays, is excellent in solution stability and thermal stability at the time of orientation, and has improved heat resistance.
【0018】また、一般式(c)において、J(活性光
線により変性ないし失活する光学活性基)は、一般式、In the general formula (c), J (an optically active group which is modified or deactivated by actinic rays) is represented by the general formula:
【化18】 (各式中、R2 はフェニル基、ビフェニル基、1−ナフ
チル基または2−ナフチル基を示し、R3 はメチル基、
フェニル基またはカルボキシメチル基を示し、R 4 はメ
チル基、ベンジル基またはt−ブチル基を示す。*は不
斉炭素原子を示す。)で表される光学活性基(j)のい
ずれかであることが好ましい。このような光学活性基
(j)により、光学活性基の有効成分含有量を容易に制
御でき、選択反射特性を向上させうる。Embedded image(In each formula, RTwo Represents a phenyl group, a biphenyl group, 1-naph
A tyl group or a 2-naphthyl group;Three Is a methyl group,
A phenyl group or a carboxymethyl group; Four Hame
It represents a tyl group, a benzyl group or a t-butyl group. * Is not
Shows asymmetric carbon atoms. ) Represents an optically active group (j)
It is preferred that it is a shift. Such an optically active group
(J) makes it possible to easily control the content of the active ingredient in the optically active group.
And the selective reflection characteristics can be improved.
【0019】本発明の配向フィルムは、前記コレステリ
ック性液晶組成物に配向処理および架橋処理を施して得
られるものである。配向フィルムはモノドメイン配向を
有する。本発明の配向フィルムは、大面積のものを容易
に効率よく製造でき、しかも架橋されているため耐熱性
に優れている。The oriented film of the present invention is obtained by subjecting the cholesteric liquid crystal composition to an orientation treatment and a crosslinking treatment. The orientation film has a monodomain orientation. The oriented film of the present invention can easily produce a large-area film easily and efficiently, and is excellent in heat resistance because it is crosslinked.
【0020】また、前記配向フィルムを多色反射板に適
用するには、前記コレステリック性液晶組成物に、複数
の領域ごとに制御された活性光線を順次又は同時に照射
して、当該コレステリック性液晶組成物中の光学活性基
の有効含有量が異なる複数の領域を形成し、その後又は
それと同時にコレステリック性液晶組成物を配向処理し
て前記領域ごとに反射波長の異なる反射領域を形成する
多色化処理工程を行った後、さらに架橋処理を施す。か
かる製造方法により、耐熱性に優れた多色反射板が得ら
れる。Further, in order to apply the alignment film to a multicolor reflector, the cholesteric liquid crystal composition is irradiated with actinic rays controlled for each of a plurality of regions sequentially or simultaneously. Multicolor processing for forming a plurality of regions having different effective contents of optically active groups in the material, and thereafter or simultaneously with the alignment treatment of the cholesteric liquid crystal composition to form a reflection region having a different reflection wavelength for each region. After performing the steps, a crosslinking treatment is further performed. According to such a manufacturing method, a multicolor reflector excellent in heat resistance can be obtained.
【0021】[0021]
【発明の実施の形態】前記架橋型ネマチック性液晶ポリ
マー(a)、架橋型コレステリック性液晶ポリマー
(b)、コレステリック性を付与するモノマー(c)
は、任意の方法で合成できる。DESCRIPTION OF THE PREFERRED EMBODIMENTS The cross-linked nematic liquid crystal polymer (a), cross-linked cholesteric liquid crystal polymer (b), and monomer (c) for imparting cholesteric properties
Can be synthesized by any method.
【0022】架橋型ネマチック性液晶ポリマー(a)
は、前記一般式(a1)および一般式(a2)で表され
る繰り返し単位を有する共重合体であり、たとえば、か
かる繰り返し単位に対応するモノマー、すなわち、ネマ
チック性液晶モノマー(a1)と架橋型ネマチック性液
晶モノマー(a2)を共重合することにより合成でき
る。Cross-linked nematic liquid crystal polymer (a)
Is a copolymer having a repeating unit represented by the general formula (a1) and the general formula (a2). For example, a monomer corresponding to such a repeating unit, that is, a nematic liquid crystal monomer (a1) and a crosslinkable It can be synthesized by copolymerizing the nematic liquid crystal monomer (a2).
【0023】また、架橋型コレステリック性液晶ポリマ
ー(b)も同様に、前記一般式(b1)および一般式
(b2)で表される繰り返し単位を有する共重合体であ
り、たとえば、かかる繰り返し単位に対応するモノマ
ー、すなわち、コレステリック性を付与するモノマー
(b1)と架橋型ネマチック性液晶モノマー(b2)を
共重合することにより合成できる。Similarly, the crosslinked cholesteric liquid crystal polymer (b) is a copolymer having the repeating units represented by the general formulas (b1) and (b2). It can be synthesized by copolymerizing a corresponding monomer, that is, a monomer (b1) imparting cholestericity and a cross-linkable nematic liquid crystal monomer (b2).
【0024】なお、一般式(a2)、一般式(b2)で
表される繰り返し単位中の架橋基は、前記の通り、架橋
型ネマチック性液晶モノマー(a2)、(b2)を共重
合する方法により共重合体中に導入できる他、当該架橋
基を導入しうるモノマーを共重合した後に、当該架橋基
を導入する方法により共重合体中に導入することもでき
る。The cross-linking group in the repeating unit represented by the general formula (a2) or (b2) is obtained by copolymerizing the cross-linkable nematic liquid crystal monomers (a2) and (b2) as described above. Can be introduced into the copolymer, or after the monomer capable of introducing the crosslinking group is copolymerized, the monomer can be introduced into the copolymer by a method of introducing the crosslinking group.
【0025】共重合体の調製は、例えばラジカル重合方
式、カチオン重合方式、アニオン重合方式などの通例の
アクリル系モノマーの重合方式に準じて行うことができ
る。なお、ラジカル重合方式を適用する場合、各種の重
合開始剤を用いうるが、そのうちアゾビスイソブチロニ
トリルや過酸化ベンゾイルなどの分解温度が高くもな
く、かつ低くもない中間的温度で分解するものが好まし
く用いられる。The copolymer can be prepared according to a conventional polymerization method of an acrylic monomer such as a radical polymerization method, a cationic polymerization method, or an anion polymerization method. When the radical polymerization method is applied, various polymerization initiators can be used, but the decomposition temperature of azobisisobutyronitrile or benzoyl peroxide is not high, and decomposes at an intermediate temperature that is not low. Are preferably used.
【0026】また、共重合体中の架橋型ネマチック性液
晶モノマー(a2)、(b2)の共重合割合は、それぞ
れの共重合体を構成するモノマーの1〜30モル%程度
とするのが好ましい。架橋型ネマチック性液晶モノマー
(a2)、(b2)の割合が少なくなると高耐熱性を得
るに十分な架橋を起こすためには、前記共重合割合は5
モル%以上とするのがより好ましい。一方、架橋型ネマ
チック性液晶モノマー(a2)の割合が多くなると液晶
としての配向性に支障をきたすおそれがあるため、前記
共重合割合は15モル%以下とするのがより好ましい。The copolymerization ratio of the crosslinked nematic liquid crystal monomers (a2) and (b2) in the copolymer is preferably about 1 to 30 mol% of the monomers constituting each copolymer. . When the proportion of the crosslinked nematic liquid crystal monomers (a2) and (b2) is reduced, the copolymerization ratio must be 5 in order to cause sufficient crosslinking to obtain high heat resistance.
More preferably, it is at least mol%. On the other hand, when the proportion of the crosslinked nematic liquid crystal monomer (a2) is increased, the orientation as a liquid crystal may be hindered. Therefore, the copolymerization proportion is more preferably 15 mol% or less.
【0027】また、液晶組成物中、架橋型ネマチック性
液晶ポリマー(a)を構成するモノマーのうちのネマチ
ック性液晶モノマー(a1)、架橋型コレステリック性
液晶ポリマー(b)を構成するモノマーのうちのコレス
テリック性を付与するモノマー(b1)、およびコレス
テリック性を付与するモノマー(c)の使用割合は、モ
ル比で、(a1):(b1)+(c)=97:3〜5
0:50が好ましく、95:5〜65:35がより好ま
しい。コレステリック性を付与するモノマー(b1)お
よび(c)の割合が過少の場合、液晶相のコレステリッ
ク性に乏しくなるおそれがあり、一方過多であれば液晶
組成物としての液晶性に乏しくなるおそれがある。In the liquid crystal composition, the nematic liquid crystal monomer (a1) among the monomers constituting the crosslinked nematic liquid crystal polymer (a) and the monomer among the monomers constituting the crosslinked cholesteric liquid crystal polymer (b) are included. The proportions of the monomer (b1) that imparts cholestericity and the monomer (c) that imparts cholestericity are (a1) :( b1) + (c) = 97: 3 to 5 in molar ratio.
0:50 is preferred, and 95: 5 to 65:35 is more preferred. If the proportion of the monomers (b1) and (c) imparting cholesteric properties is too small, the cholesteric properties of the liquid crystal phase may be poor, while if too large, the liquid crystal properties of the liquid crystal composition may be poor. .
【0028】架橋型ネマチック性液晶ポリマー(a)、
架橋型コレステリック性液晶ポリマー(b)の分子量
は、重量平均分子量に基づき2千〜10万程度とするの
が好ましい。分子量が小さくなると、非流動層としての
成膜性に乏しくなるため2.5千以上とするのがより好
ましい。また、分子量が大きくなると、液晶としての配
向性、特にラビング配向膜等を介したモノドメイン化に
乏しくなって均一な配向状態を形成しにくくなることよ
り、5万以下とするがより好ましい。Cross-linked nematic liquid crystal polymer (a),
The molecular weight of the crosslinked cholesteric liquid crystal polymer (b) is preferably about 2,000 to 100,000 based on the weight average molecular weight. When the molecular weight is small, the film-forming property as a non-fluidized layer is poor, so that it is more preferably at least 25,000. In addition, when the molecular weight is large, the orientation as a liquid crystal, in particular, monodomain formation via a rubbing orientation film or the like is poor, and it is difficult to form a uniform orientation state.
【0029】以下に、下記式(α)で表わされる架橋型
ネマチック性液晶ポリマー(a)の合成例の一例を下記
化19に示す。An example of the synthesis of the crosslinked nematic liquid crystal polymer (a) represented by the following formula (α) is shown in the following chemical formula (19).
【0030】[0030]
【化19】 すなわち、ネマチック性液晶モノマー(a1)は、4−
(2−プロペノイルオキシエトキシ)安息香酸と4−シ
アノ−4’−ヒドロキシビフェニルを、ジシクロヘキシ
ルカルボジイミド(式中、DCC)とジメチルアミノピ
リジン(式中、DMAP)の存在下にエステル化するこ
とによりを得ることができる。Embedded image That is, the nematic liquid crystal monomer (a1)
By esterifying (2-propenoyloxyethoxy) benzoic acid and 4-cyano-4'-hydroxybiphenyl in the presence of dicyclohexylcarbodiimide (where DCC) and dimethylaminopyridine (where DMAP). Obtainable.
【0031】また、架橋型ネマチック性液晶モノマー
(a2)は、たとえば、4−(4’−ヒドロキシフェニ
ル)安息香酸を水酸化ナトリウム水溶液中、クロロ炭酸
メチルを加え室温で撹拌して水酸基を保護した後、1,
2,5,6−テトラヒドロベンジルアルコールを反応さ
せてテトラヒドロベンジル基を導入し、その後25%ア
ンモニア水/テトラヒドロフラン(THF)の混合液
(重量比:1/10)中で加熱還流し保護基を切断し、
さらに4−(2−プロペノイルオキシエトキシ)安息香
酸を加え、DCCとDMAPの存在下にエステル化する
により得ることができる。The cross-linkable nematic liquid crystal monomer (a2) is, for example, 4- (4'-hydroxyphenyl) benzoic acid in an aqueous sodium hydroxide solution by adding methyl chlorocarbonate and stirring at room temperature to protect the hydroxyl group. Later, 1,
2,5,6-Tetrahydrobenzyl alcohol is reacted to introduce a tetrahydrobenzyl group, and then heated and refluxed in a 25% aqueous ammonia / tetrahydrofuran (THF) mixture (weight ratio: 1/10) to cleave the protective group. And
Further, it can be obtained by adding 4- (2-propenoyloxyethoxy) benzoic acid, followed by esterification in the presence of DCC and DMAP.
【0032】そして、これらのモノマーをアゾビスイソ
ブチロニトリル(式中、AIBN)触媒下で共重合する
ことによって、化学式(α)で表わされる架橋型ネマチ
ック性液晶ポリマー(a)を得ることができる。なお、
化19中のl、mは、ポリマー中の各繰り返し単位の割
合(モル%)を示し、l:m=99:1〜70:30を
満足するものであり、便宜的にブロック共重合体で表し
たが、前記一般式(a1)および一般式(a2)で表さ
れる繰り返し単位はブロック型、ランダム型のいずれで
もよい。Then, these monomers are copolymerized under the azobisisobutyronitrile (AIBN) catalyst to obtain a crosslinked nematic liquid crystal polymer (a) represented by the chemical formula (α). it can. In addition,
1 and m in Chemical formula 19 represent the ratio (mol%) of each repeating unit in the polymer, and satisfy l: m = 99: 1 to 70:30. As described above, the repeating units represented by the general formulas (a1) and (a2) may be block type or random type.
【0033】かかる前記式(α)の構造は本発明におけ
る架橋型ネマチック性液晶ポリマー(a)の一例であ
り、本発明における架橋型ネマチック性液晶ポリマー
(a)が前記式(α)に限定されるものではない。The structure of the above formula (α) is an example of the crosslinked nematic liquid crystal polymer (a) in the present invention, and the crosslinked nematic liquid crystal polymer (a) in the present invention is limited to the above formula (α). Not something.
【0034】なお、ネマチック性液晶モノマー(a1)
および架橋型ネマチック性液晶モノマー(a2)の合成
に用いた、4−(2−プロペノイルオキシエトキシ)安
息香酸の合成は、下記化20に示す通りエチレンクロロ
ヒドリンと4−ヒドロキシ安息香酸をヨウ化カリウムを
触媒としてアルカリ水溶液中で加熱還流させて、ヒドロ
キシカルボン酸を得た後、それをアクリル酸と脱水反応
させて得ることができる。The nematic liquid crystal monomer (a1)
The synthesis of 4- (2-propenoyloxyethoxy) benzoic acid used for the synthesis of the cross-linked nematic liquid crystal monomer (a2) was carried out using ethylene chlorohydrin and 4-hydroxybenzoic acid as shown in the following Chemical Formula 20. After heating and refluxing in an aqueous alkali solution using potassium chloride as a catalyst to obtain a hydroxycarboxylic acid, it can be obtained by subjecting it to a dehydration reaction with acrylic acid.
【0035】[0035]
【化20】 また、下記式(β)で表わされる架橋型コレステリック
性液晶ポリマー(b)の合成例の一例を下記化21に示
す。Embedded image In addition, an example of a synthesis example of the crosslinked cholesteric liquid crystal polymer (b) represented by the following formula (β) is shown in the following formula 21.
【0036】[0036]
【化21】 すなわち、コレステリック性を付与するモノマー(b
1)は、例えば、イソソルビドをTHF中、p−トルエ
ンスルホン酸とジヒドロピラン(DHP)を加え温室で
撹拌して片側の水酸基のみを保護した後、これをp−シ
アノ安息香酸とDCCおよびDMAP存在下にエステル
化反応させ、次いで塩酸/THF溶液中で撹拌して保護
基を切断した後、4− (2−プロペノイルオキシエトキ
シ)安息香酸とDCCおよびDMAP存在下にエステル
反応することにより得ることができる。Embedded image That is, a monomer (b) that imparts cholesteric properties
1) For example, isosorbide is added to p-toluenesulfonic acid and dihydropyran (DHP) in THF and stirred in a greenhouse to protect only one hydroxyl group. Then, this is added to p-cyanobenzoic acid, DCC and DMAP. Esterification reaction, followed by stirring in a hydrochloric acid / THF solution to cleave the protecting group, followed by esterification with 4- (2-propenoyloxyethoxy) benzoic acid in the presence of DCC and DMAP. Can be.
【0037】また、架橋型ネマチック性液晶モノマー
(b2)は、前記架橋型ネマチック性液晶モノマー(a
2)と同じ構造であり同様の方法により得られる。これ
ら架橋型ネマチック性液晶モノマー(a2)、(b2)
は液晶組成物の液晶性、配向性などを損なわないもので
あれば、架橋型ネマチック性液晶モノマー(a2)、
(b2)は同一でも、異なっていてもよく、特に制限な
く適宜に選択して使用できる。なお、化21中の架橋型
ネマチック性液晶モノマー(b2)は、化20中の架橋
型ネマチック性液晶モノマー(a2)と同様のものを用
いた場合を示す。The cross-linked nematic liquid crystal monomer (b2) is the same as the cross-linked nematic liquid crystal monomer (a).
It has the same structure as in 2) and can be obtained by a similar method. These crosslinked nematic liquid crystal monomers (a2) and (b2)
Is a cross-linkable nematic liquid crystal monomer (a2), as long as it does not impair the liquid crystallinity and orientation of the liquid crystal composition.
(B2) may be the same or different, and can be appropriately selected and used without particular limitation. The crosslinked nematic liquid crystal monomer (b2) in Chemical Formula 21 shows the case where the same one as the crosslinked nematic liquid crystal monomer (a2) in Chemical Formula 20 is used.
【0038】そして、これらのモノマーをアゾビスイソ
ブチロニトリル(式中、AIBN)触媒下で共重合する
ことによって、化学式(β)で表わされる架橋型コレス
テリック性液晶ポリマー(b)を得ることができる。な
お、化21中のx、yはポリマー中の各繰り返し単位の
割合を示し、x:y=97:3〜50:50を満足する
ものであり、便宜的にブロック共重合体で表したが、前
記一般式(b1)および一般式(b2)で表される繰り
返し単位はブロック型、ランダム型のいずれでもよい。Then, these monomers are copolymerized under an azobisisobutyronitrile (AIBN) catalyst to obtain a crosslinked cholesteric liquid crystal polymer (b) represented by the chemical formula (β). it can. In addition, x and y in Chemical formula 21 show the ratio of each repeating unit in a polymer, and satisfy x: y = 97: 3 to 50:50, and are represented by a block copolymer for convenience. The repeating units represented by the general formulas (b1) and (b2) may be any of a block type and a random type.
【0039】かかる前記式(β)の構造は本発明におけ
る架橋型コレステリック性液晶ポリマー(b)の一例で
あり、本発明における架橋型コレステリック性液晶ポリ
マー(b)が前記式(β)に限定されるものではない。The structure of the formula (β) is an example of the crosslinked cholesteric liquid crystal polymer (b) in the present invention, and the crosslinked cholesteric liquid crystal polymer (b) in the present invention is limited to the formula (β). Not something.
【0040】また、下記式(γ)で表わされるコレステ
リック性を付与するモノマー(c)の合成例の一例を下
記化22に示す。An example of the synthesis of the monomer (c) imparting cholestericity represented by the following formula (γ) is shown in the following formula (22).
【0041】[0041]
【化22】 すなわち、4−(2−プロペノイルオキシエトキシ)安
息香酸と4位にシッフ塩基を介して光学活性基を有する
フェノールを、DCCおよびDMAP触媒存在下でエス
テル化することによりコレステリック性を付与するモノ
マー(γ)を合成できる。Embedded image That is, a monomer that imparts cholestericity by esterifying 4- (2-propenoyloxyethoxy) benzoic acid and a phenol having an optically active group at the 4-position via a Schiff base in the presence of a DCC and DMAP catalyst ( γ) can be synthesized.
【0042】前記コレステリック性を付与するモノマー
(c)の合成に用いた、4位にシッフ塩基を介して光学
活性基を有するフェノールは、例えば下記化23のよう
に、4−ヒドロキシベンズアルデヒドと(S)−(−)
−1−フェニルエチルアミンをトルエン中で共沸脱水す
ることにより得ることができる。The phenol having an optically active group at the 4-position via a Schiff base used in the synthesis of the monomer (c) imparting cholestericity is, for example, 4-hydroxybenzaldehyde and (S )-(-)
It can be obtained by azeotropically dehydrating -1-phenylethylamine in toluene.
【0043】[0043]
【化23】 かかる前記式(γ)の構造は本発明におけるコレステリ
ック性を付与するモノマー(c)の一例であり、本発明
におけるコレステリック性を付与するモノマー(c)が
前記式(γ)に限定されるものではない。Embedded image Such a structure of the formula (γ) is an example of the cholestericity imparting monomer (c) in the present invention, and the cholestericity imparting monomer (c) in the present invention is not limited to the formula (γ). Absent.
【0044】本発明のコレステリック性液晶組成物は、
前記架橋型ネマチック性液晶ポリマー(a)、架橋型コ
レステリック性液晶ポリマー(b)およびコレステリッ
ク性を付与するモノマー(c)を含有してなるものであ
る。なお、これらの液晶ポリマー、液晶モノマーは、そ
れぞれ前記一般式で表されるものを2種以上混合して用
いてもよい。The cholesteric liquid crystal composition of the present invention comprises
The cross-linkable nematic liquid crystal polymer (a), the cross-linked cholesteric liquid crystal polymer (b), and the monomer (c) for imparting cholesteric properties are included. In addition, these liquid crystal polymers and liquid crystal monomers may be used by mixing two or more kinds represented by the above general formula.
【0045】液晶組成物中、架橋型ネマチック性液晶ポ
リマー(a)の組成割合は、過少だと液晶性に乏しくな
り、配向できないおそれがあるため、50〜95重量%
程度とするのが好ましい。さらには、架橋型ネマチック
性液晶ポリマー(a)の含有量は、65〜90重量%と
するのがより好ましい。If the composition ratio of the crosslinked nematic liquid crystal polymer (a) in the liquid crystal composition is too small, the liquid crystallinity becomes poor and there is a possibility that the liquid crystal composition cannot be aligned.
It is preferable to set the degree. Further, the content of the crosslinked nematic liquid crystal polymer (a) is more preferably 65 to 90% by weight.
【0046】また、液晶組成物中、架橋型コレステリッ
ク性液晶ポリマー(b)およびコレステリック性を付与
するモノマー(c)の合計の割合は、架橋型ネマチック
性液晶ポリマー(a)の残部となる。また、コレステリ
ック性を付与するモノマー(c)の割合は、架橋型コレ
ステリック性液晶ポリマー(b)を構成するコレステリ
ック性を付与するモノマー(b1)に対し、通常、10
〜1000モル%程度、さらには30〜300モル%に
なるように調整するのが好ましい。コレステリック性を
付与するモノマー(c)が過多の場合、溶液安定性や熱
的安定性に劣る光学活性基が選択反射波長制御後にも残
存することとなり、好ましくない。一方、過少になる
と、単色用に用いる場合には特に問題はないが、選択反
射光を多色化して用いる場合には選択反射波長を制御で
きる範囲が極端に小さくなり、多色反射板の作製上好ま
しくない。The total proportion of the crosslinked cholesteric liquid crystal polymer (b) and the cholesteric monomer (c) in the liquid crystal composition is the balance of the crosslinked nematic liquid crystal polymer (a). The proportion of the monomer (c) for imparting cholesteric property is usually 10% with respect to the monomer (b1) for imparting cholesteric property constituting the crosslinked cholesteric liquid crystal polymer (b).
It is preferably adjusted to about 1000 mol%, more preferably 30 to 300 mol%. If the amount of the monomer (c) imparting cholesteric properties is excessive, an optically active group having poor solution stability and thermal stability will remain after controlling the selective reflection wavelength, which is not preferable. On the other hand, when the amount is too small, there is no particular problem when used for a single color, but when the selectively reflected light is used in multiple colors, the range in which the selective reflection wavelength can be controlled becomes extremely small, and the production of a multicolor reflector Not preferred.
【0047】なお、本発明のコレステリック性液晶組成
物は、前記液晶ポリマー(a)、(b)、液晶モノマー
(c)を各種用途に応じて適宜に選択し、上記方法に準
じて合成したものから調製するが、本発明の目的を損な
わない範囲で、前記液晶モノマー以外の液晶モノマー
や、液晶ポリマーを含有することができる。The cholesteric liquid crystal composition of the present invention is obtained by appropriately selecting the liquid crystal polymers (a), (b) and the liquid crystal monomer (c) according to various uses, and synthesizing according to the above method. However, a liquid crystal monomer other than the liquid crystal monomer and a liquid crystal polymer can be contained within a range not to impair the object of the present invention.
【0048】本発明のコレステリック性液晶組成物は、
配向処理および架橋処理が施されてモノドメイン配向を
有する配向フィルムとなる。The cholesteric liquid crystal composition of the present invention comprises
The orientation film and the cross-linking process are performed to form an oriented film having a monodomain orientation.
【0049】配向処理は、従来の光学素子の形成に準じ
たは配向処理方法で行いうる。たとえば、コレステリッ
ク性液晶組成物の溶液を配向処理面上に展開して乾燥
後、加熱処理して配向層を形成する。The orientation treatment can be performed by an orientation treatment method according to the conventional formation of an optical element. For example, a solution of the cholesteric liquid crystal composition is spread on an alignment-treated surface, dried, and then heat-treated to form an alignment layer.
【0050】前記の液晶組成物溶液の調製に際して用い
る溶媒としては、前記液晶ポリマー(a)、(b)、モ
ノマー(c)を溶解しうるものであれば特に限定はな
く、このようなものを適宜に選択して用いることができ
るる。たとえば、1,1,2,2−テトラクロロエタ
ン、シクロヘキサノン、塩化メチレン、クロロホルム、
テトラヒドロフラン等があげられる。これらの溶媒は単
独溶媒や混合溶媒として用いられる。The solvent used for preparing the liquid crystal composition solution is not particularly limited as long as it can dissolve the liquid crystal polymers (a), (b) and the monomer (c). It can be appropriately selected and used. For example, 1,1,2,2-tetrachloroethane, cyclohexanone, methylene chloride, chloroform,
Tetrahydrofuran and the like. These solvents are used as a single solvent or a mixed solvent.
【0051】配向処理面としては、例えば低分子液晶化
合物の配向処理に使用されている公知のものを用いるこ
とかできる。たとえば、基材上にボリイミドやポリビニ
ルアルコール等からなる薄膜を形成して、それをレーヨ
ン布等でラビング処理したものや、酸化珪素等を斜方蒸
着したもの、あるいは延伸フィルムなどがあげられる。
基材等としては、液晶組成物を配向させるための加熱処
理に耐えるものであれば特に制限されず、例えばガラス
板やポリマーシート、位相差板や偏光板等を適宜に選択
して用いうる。As the alignment treatment surface, for example, a known surface used for alignment treatment of a low-molecular liquid crystal compound can be used. For example, a thin film made of polyimide, polyvinyl alcohol, or the like is formed on a substrate and rubbed with a rayon cloth or the like, obliquely vapor-deposited silicon oxide, or a stretched film.
The substrate or the like is not particularly limited as long as it can withstand heat treatment for aligning the liquid crystal composition. For example, a glass plate, a polymer sheet, a retardation plate, a polarizing plate, or the like can be appropriately selected and used.
【0052】液晶組成物溶液の展開は、たとえば、その
溶液を、スピンコート法やロールコート法、フローコー
ト法やプリント法、デイップコート法や流延製膜法等の
方法で薄層展開し、それを乾燥処理して溶媒を除去する
方法などにより行うことができる。The liquid crystal composition solution is developed by, for example, developing the solution into a thin layer by a method such as a spin coating method, a roll coating method, a flow coating method, a printing method, a dip coating method or a casting film forming method. It can be carried out by a method of drying and removing the solvent.
【0053】液晶組成物の展開層を配向させるための加
熱処理は、液晶組成物のガラス転移点から等方相を呈す
る溶融状態までの温度範囲に加熱することにより行うこ
とができる。なお、配向状態を固定化するための冷却条
件については特に限定はなく、通例前記の加熱処理を3
00℃以下で行いうることから、自然冷却方式が一般に
用いられる。The heat treatment for aligning the spread layer of the liquid crystal composition can be performed by heating the liquid crystal composition to a temperature range from a glass transition point to a molten state exhibiting an isotropic phase. The cooling conditions for fixing the alignment state are not particularly limited, and generally, the above-described heat treatment is performed for 3 hours.
Since it can be performed at a temperature of 00 ° C. or less, a natural cooling method is generally used.
【0054】配向処理を終えた展開層は、それを架橋処
理することにより配向架橋物とされるが、その架橋処理
は電磁波照射および加熱の一方、または両方により行う
ことができる。電磁波は、紫外線や電子線等の適宜なも
のを用いうるが、中でも開始剤を添加する必要が無く初
期配向性に影響の少ない電子線を好ましく用いうる。電
磁波の波長、照射量は適宜決めることができるが、紫外
線を用いる場合は液晶組成物の吸収のない300nmよ
り長波長の紫外線が好ましく、電子線を用いる場合は、
照射量が多すぎると液晶ポリマーが崩壊するので、系に
よるがおおむね1〜200Mrad/cm2 が好まし
い。The developed layer after the orientation treatment is cross-linked to form an oriented cross-linked product. The cross-linking treatment can be performed by one or both of electromagnetic wave irradiation and heating. As the electromagnetic wave, an appropriate one such as an ultraviolet ray or an electron beam can be used. Among them, an electron beam which does not need to add an initiator and has little influence on the initial orientation can be preferably used. The wavelength of the electromagnetic wave and the irradiation amount can be determined as appropriate, but when using ultraviolet light, ultraviolet light having a wavelength longer than 300 nm that does not absorb the liquid crystal composition is preferable, and when using an electron beam,
If the irradiation amount is too large, the liquid crystal polymer will be destroyed. Therefore, depending on the system, it is preferably about 1 to 200 Mrad / cm 2 .
【0055】配向後の架橋を引き起こすために用いうる
開始剤は架橋形態によって異なるが、いずれの場合も開
始剤の添加による配向処理物の着色が実用上問題のない
程度であることが望ましい。まず加熱のみによって架橋
を行う場合は、配向処理時に架橋が起らないよう、分解
温度の高い開始剤を用いる必要がある。次に電磁波架橋
のうち開始剤が必要な紫外線について言及すると、紫外
線照射のみ、もしくは加熱しながら紫外線照射によって
架橋を行ういずれの場合も、配向温度および架橋時の加
熱温度で分解するものは好ましくなく、液晶組成物の吸
収がある300nmより長波長の紫外線で分解する開始
剤であれば使用できる。例えば、2‐ベンジル−2−ジ
メチルアミノ−1−(4−モルフォリノフェニル)−ブ
タノン−1や、オリゴ[2−ヒドロキシ−2−メチル−
1−[4−(1−メチルビニル)フェニル]プロパノ
ン]などが好ましく用いられる。また添加する開始剤量
も適宜決めることができる。The initiator that can be used to cause cross-linking after alignment differs depending on the type of cross-linking. In any case, it is desirable that coloring of the alignment-treated product by the addition of the initiator is of a level that causes no practical problem. First, when crosslinking is performed only by heating, it is necessary to use an initiator having a high decomposition temperature so that crosslinking does not occur during the alignment treatment. Next, referring to the ultraviolet light required for the initiator among the electromagnetic wave crosslinking, only ultraviolet irradiation, or in any case of performing crosslinking by ultraviolet irradiation while heating, those that decompose at the orientation temperature and the heating temperature at the time of crosslinking are not preferred. Any initiator that absorbs the liquid crystal composition and decomposes by ultraviolet rays having a wavelength longer than 300 nm can be used. For example, 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) -butanone-1 or oligo [2-hydroxy-2-methyl-
1- [4- (1-methylvinyl) phenyl] propanone] and the like are preferably used. Further, the amount of the initiator to be added can be determined as appropriate.
【0056】電磁波照射に際しては、酸素阻害による影
響を回避するため減圧下や無酸素下等で行うことが好ま
しい。なお加熱処理の場合、液晶組成物のガラス転移温
度より高く、等方相転移温度より低い温度範囲の中の適
宜な温度で加熱してよい。The irradiation of the electromagnetic wave is preferably performed under reduced pressure or oxygen-free condition to avoid the influence of oxygen inhibition. In the case of heat treatment, the liquid crystal composition may be heated at an appropriate temperature within a temperature range higher than the glass transition temperature and lower than the isotropic phase transition temperature.
【0057】本発明の配向フィルムは、適宜な基材上に
配向処理した液晶層を有する形態や、配向処理した液晶
層の単独層からなるフィルム形態などの適宜な形態を有
するものであってよい。液晶単独層からなるフィルムは
配向処理面よりの剥離物として得ることができるが、そ
の剥離回収には、長鎖アルキル基等からなる剥離性側鎖
を有するラビング膜形成剤を用いる方式や、炭素数8〜
18のアルキル鎖を有するシラン化合物を表面に結合修
飾させたガラス板に配向処理面を形成する方式などの適
宜な方式を必要に応じて適用することができる。The oriented film of the present invention may have an appropriate form such as a form having a liquid crystal layer subjected to an alignment treatment on an appropriate substrate or a film form comprising a single layer of the liquid crystal layer subjected to an alignment treatment. . A film composed of a single layer of liquid crystal can be obtained as a peeled product from the alignment-treated surface. Number 8-
An appropriate method such as a method of forming an alignment-treated surface on a glass plate having a surface modified with a silane compound having an alkyl chain of 18 can be applied as needed.
【0058】一方、基材との重畳物からなる配向フィル
ムとする場合、その基材としては、プラスチックフィル
ムやガラス板、あるいはポリマーシート、位相差板等の
延伸フィルムや偏光板の如き光学フィルムなど適宜のも
のを用いうる。前記のプラスチックフィルムとしては、
例えばポリメチルメタクリレートやポリカーボネート、
ポリビニルアルコールやポリアクリレート、ポリプロピ
レンやその他のポリオレフィン、ポリスチレンなどの、
延伸フィルムを形成しうる光学的に透明なプラスチック
を適宜に選択して用いうる。なお、基材としては、ガラ
ス板やトリアセチルセルロースフィルムの如く複屈折に
よる位相差が可及的に小さいものが特に望ましい。On the other hand, in the case of an oriented film comprising a superimposed material with a substrate, the substrate may be a plastic film, a glass plate, a stretched film such as a polymer sheet or a retardation plate, or an optical film such as a polarizing plate. An appropriate one can be used. As the plastic film,
For example, polymethyl methacrylate or polycarbonate,
Polyvinyl alcohol and polyacrylate, polypropylene and other polyolefins, such as polystyrene,
An optically transparent plastic capable of forming a stretched film can be appropriately selected and used. In addition, as the base material, a material having as small a retardation as possible due to birefringence, such as a glass plate or a triacetyl cellulose film, is particularly desirable.
【0059】なお、配向架橋処理した液晶層の厚さは、
使用目的に応じた光学特性などにより適宜に決定しうる
が、一般には柔軟性等の点より100μm以下、就中5
0μm、特に1〜30μmとされる。The thickness of the liquid crystal layer subjected to the alignment crosslinking treatment is as follows:
Although it can be appropriately determined according to the optical characteristics and the like according to the purpose of use, it is generally 100 μm or less in view of flexibility and the like.
0 μm, especially 1 to 30 μm.
【0060】このようにして得られた本発明の配向フィ
ルムは、円偏光二色性を示す光学フィルムとして、液晶
表示素子等の色補償板、光学位相板、コレステリックフ
ィルム、ノッチフィルター等の種々の光学フィルム用途
に有用なものである。The thus-obtained oriented film of the present invention can be used as an optical film exhibiting circular dichroism as a color compensating plate such as a liquid crystal display device, an optical phase plate, a cholesteric film, a notch filter and the like. It is useful for optical film applications.
【0061】また、本発明のコレステリック性液晶組成
物は、基材層に展開した液晶相に対し、複数の領域ごと
に制御された活性光線を順次又は同時に照射して、当該
コレステリック性液晶組成物中の光学活性基の有効含有
量が異なる複数の領域を形成し、その後又はそれと同時
にコレステリック性液晶組成物を配向処理して前記領域
ごとに反射波長の異なる反射領域を形成する多色化処理
工程を行った後、さらに架橋処理を施すことにより、コ
レステリック性液晶の選択反射特性を任意に設定した、
耐熱性に優れる多色反射板を製造できる。Further, the cholesteric liquid crystal composition of the present invention is obtained by irradiating a liquid crystal phase spread on a base material layer with active rays controlled in a plurality of regions sequentially or simultaneously, thereby obtaining the cholesteric liquid crystal composition. Forming a plurality of regions having different effective contents of the optically active groups therein, and thereafter or simultaneously with the alignment treatment of the cholesteric liquid crystal composition to form a reflection region having a different reflection wavelength for each region. After that, by further performing a cross-linking treatment, the selective reflection characteristics of the cholesteric liquid crystal were arbitrarily set,
A multicolor reflector excellent in heat resistance can be manufactured.
【0062】活性光線としては、光学活性基を変性ない
し失活させうる、例えば可視光線や紫外線、電子線やガ
ンマ線などの適宜な放射線を用いることが出来る。その
中でも、照射エネルギー等の点より水銀灯やエキシマレ
ーザー等を介した紫外線が好ましい。As the actinic ray, an appropriate ray such as a visible ray, an ultraviolet ray, an electron beam or a gamma ray which can modify or deactivate the optically active group can be used. Among them, ultraviolet rays via a mercury lamp, excimer laser, or the like is preferable from the viewpoint of irradiation energy and the like.
【0063】活性光線の照射により、コレステリック性
を付与するモノマー(c)中の光学活性基(J)に係わ
るシッフ塩基等の結合基が切断され、光学活性基の有効
含有量が異なる複数の領域が形成され、コレステリック
性液晶の選択反射特性を任意に設定可能である。By the irradiation with actinic rays, a binding group such as a Schiff base relating to the optically active group (J) in the monomer (c) imparting cholestericity is cleaved, and a plurality of regions having different effective contents of the optically active group. Is formed, and the selective reflection characteristic of the cholesteric liquid crystal can be set arbitrarily.
【0064】多色反射板の製造における配向処理、架橋
処理は、前記と同様の処理法を採用でき、配向処理は活
性光線の照射と同時に行うこともできる。なお、活性光
線の照射にあたっては、基材層に展開した液晶相を予め
配向処理しておくことにより、活性光線の照射後または
同時における配向処理を良好に行いうる。The orientation and cross-linking treatments in the production of the multicolor reflector can be performed in the same manner as described above, and the orientation treatment can be carried out simultaneously with the irradiation of actinic rays. In addition, when irradiating with an actinic ray, the liquid crystal phase developed on the base material layer is subjected to an orientation treatment in advance, so that the orientation treatment can be favorably performed after or simultaneously with the irradiation with the actinic ray.
【0065】また、前記液晶組成物に光酸発生剤を配合
して非流動層とすることにより、結合基の切断に必要な
活性光線の照射量を減量できるが、かかる光酸発生剤を
添加した場合には、光学活性基に係わるウレタン結合や
−OCOO−結合においても切断が可能となる。その配
合量は、液晶組成物100重量部に対し25重量部以
下、就中0.1〜20重量部、特に0.5〜10重量部
が一般的であるが、これに限定されない。Further, by adding a photoacid generator to the liquid crystal composition to form a non-fluidized bed, the amount of irradiation with actinic rays necessary for cutting the bonding group can be reduced. In this case, cleavage can be performed even at a urethane bond or an -OCOO- bond relating to the optically active group. The compounding amount is generally 25 parts by weight or less, preferably 0.1 to 20 parts by weight, particularly 0.5 to 10 parts by weight, based on 100 parts by weight of the liquid crystal composition, but is not limited thereto.
【0066】光酸発生剤としては、例えばトリアジン
類、芳香族スルホニウム塩類、芳香族ジアゾニウム塩
類、シアン酸エステル類、芳香族スルホン酸エステル
類、ニトロベンジルエステル類、芳香族スルファミド類
などの適宜なものを用いうる。就中、配合効果や液晶配
向への無影響性などの点より、トリアジン類や芳香族ス
ルホニウム塩類が好ましく用いうる。Suitable photoacid generators include, for example, triazines, aromatic sulfonium salts, aromatic diazonium salts, cyanate esters, aromatic sulfonates, nitrobenzyl esters, aromatic sulfamides and the like. Can be used. Above all, triazines and aromatic sulfonium salts can be preferably used from the viewpoints of the compounding effect and no influence on the liquid crystal alignment.
【0067】前記したトリアジン類の具体例としては、
2,4−ビス(トリクロロメチル)−6−(3’,4’
−ジメトキシフェニル)トリアジン、2,4−ビス(ト
リクロロメチル)−6−(4’−メトキシナフチル)ト
リアジン、2,4−ビス(トリクロロメチル)−6−ビ
ペロニルトリアジン、2,4−ビス(トリクロロメチ
ル)−6−(4’−メトキシ−β−スチリル)トリアジ
ン、2,4−ビス(トリクロロメチル)−6−(3’−
クロロ−4’−メトキシ−β−スチリル)トリアジンな
どが挙げられるが、これらに限定されるものではない。Specific examples of the above triazines include:
2,4-bis (trichloromethyl) -6- (3 ′, 4 ′
-Dimethoxyphenyl) triazine, 2,4-bis (trichloromethyl) -6- (4'-methoxynaphthyl) triazine, 2,4-bis (trichloromethyl) -6-biperonyltriazine, 2,4-bis ( Trichloromethyl) -6- (4′-methoxy-β-styryl) triazine, 2,4-bis (trichloromethyl) -6- (3′-
Chloro-4′-methoxy-β-styryl) triazine and the like, but are not limited thereto.
【0068】また、芳香族スルホニウム塩類の具体例と
しては、下記の化学式で表されるものなどが挙げられ
る。Further, specific examples of the aromatic sulfonium salts include those represented by the following chemical formula.
【0069】[0069]
【化24】 Embedded image
【実施例】以下、本発明の構成と効果を具体的に示す実
施例等について説明する。DESCRIPTION OF THE PREFERRED EMBODIMENTS Embodiments and the like specifically showing the configuration and effects of the present invention will be described below.
【0070】製造例1(ネマチック性液晶モノマー(a
1)の合成)Production Example 1 (Nematic liquid crystal monomer (a
Synthesis of 1))
【化25】 水酸化カリウム300gをエタノール700mlと水3
00mlの混合液に溶解し、その溶液に4−ヒドロキシ
安息香酸276gと触媒量のヨウ化カリウムを溶解させ
た後、加温状態でエチレンクロロヒドリン177gを徐
々に添加して約15時間還流させた。得られた反応液よ
りエタノールを留去し、次いで水2L中に入れ、この水
溶液をジエチルエーテルで2回洗浄後、塩酸を添加して
酸性液とした。さらに沈殿物を濾別乾燥した後、エタノ
ールで再結晶し、4−(2−ヒドロキシエトキシ)安息
香酸298gを得た。Embedded image 300 g of potassium hydroxide, 700 ml of ethanol and 3
After dissolving 276 g of 4-hydroxybenzoic acid and a catalytic amount of potassium iodide in the solution, 177 g of ethylene chlorohydrin was gradually added while heating, and the mixture was refluxed for about 15 hours. Was. Ethanol was distilled off from the obtained reaction solution, and then the solution was poured into 2 L of water. The aqueous solution was washed twice with diethyl ether, and hydrochloric acid was added to obtain an acidic solution. Further, the precipitate was separated by filtration and dried, and then recrystallized from ethanol to obtain 298 g of 4- (2-hydroxyethoxy) benzoic acid.
【0071】次に、前記の4−(2−ヒドロキシエトキ
シ)安息香酸18.2gをテトラヒドロフラン300m
lに溶解させた後、それにアクリル酸ビニル19.5g
とリパーゼPS(天野製薬(株)製)18.0gと少量
のp−メトキシフェノールを添加して40℃で3時間撹
拌した。得られた反応液よりリパーゼPSを濾別後、そ
の濾液を減圧留去した。生成の固体を2−ブタノン/ヘ
キサン=2/1 (重量比)の混合溶媒で再結晶させて4
−(2−プロベノイルオキシエトキシ)安息香酸17.
5gを得た。Then, 18.2 g of the above 4- (2-hydroxyethoxy) benzoic acid was added to 300 m of tetrahydrofuran.
19.5 g of vinyl acrylate
And 18.0 g of Lipase PS (manufactured by Amano Pharmaceutical Co., Ltd.) and a small amount of p-methoxyphenol were added, followed by stirring at 40 ° C. for 3 hours. After lipase PS was filtered off from the obtained reaction solution, the filtrate was distilled off under reduced pressure. The resulting solid was recrystallized with a mixed solvent of 2-butanone / hexane = 2/1 (weight ratio) to give 4
-(2-Provenoyloxyethoxy) benzoic acid17.
5 g were obtained.
【0072】次に、4−(2−プロペノイルオキシエト
キシ)安息香酸9.44g、トリフルオロ酢酸無水物
8.32mlを塩化メチレン100ml中に入れ、撹拌
しながら4−シアノ−4’−ヒドロキシビフェニル7.
8gを加え、室温で6時間反応させた。反応液に塩化メ
チレン300mlを加え、水、飽和炭酸水素ナトリウム
水溶液、飽和食塩水で洗浄し、無水硫酸ナトリウムで乾
燥した。濾過、濃縮後、アセトニトリル150mlより
再結晶を行い、ネマチック性液晶モノマー11.7g
(化学純度>98%)を得た。Next, 9.44 g of 4- (2-propenoyloxyethoxy) benzoic acid and 8.32 ml of trifluoroacetic anhydride were put into 100 ml of methylene chloride, and 4-cyano-4'-hydroxybiphenyl was added with stirring. 7.
8 g was added and reacted at room temperature for 6 hours. 300 ml of methylene chloride was added to the reaction solution, and the mixture was washed with water, a saturated aqueous solution of sodium hydrogencarbonate and saturated saline, and dried over anhydrous sodium sulfate. After filtration and concentration, recrystallization was performed from 150 ml of acetonitrile to obtain 11.7 g of a nematic liquid crystal monomer.
(Chemical purity> 98%).
【0073】製造例2(架橋型ネマチック性液晶モノマ
ー(a2)の合成)Production Example 2 (Synthesis of Crosslinked Nematic Liquid Crystalline Monomer (a2))
【化26】 水2000mlに、水酸化ナトリウム83.86gおよ
び4−ヒドロキシ安息香酸100gを溶解した溶液を氷
冷しておき、その中にクロロぎ酸メチル91.1mlを
撹拌しながら滴下した後、室温に戻しながら4時間撹拌
した。この溶液を水浴上で冷却しながら、この溶液に濃
塩酸約70mlを加えてpH2〜3に調整し、析出した
結晶を濾過、水洗いして乾燥させた。さらに、イソプロ
パノール1000mlから再結晶し、4−メトキシカル
ボニルオキシ安息香酸94.0g(収率66,2%、化
学純度>99%)を得た。Embedded image A solution prepared by dissolving 83.86 g of sodium hydroxide and 100 g of 4-hydroxybenzoic acid in 2000 ml of water was cooled on ice, and 91.1 ml of methyl chloroformate was added dropwise thereto with stirring, and then returned to room temperature. Stir for 4 hours. While cooling this solution on a water bath, about 70 ml of concentrated hydrochloric acid was added to the solution to adjust the pH to 2-3, and the precipitated crystals were filtered, washed with water and dried. Further, the product was recrystallized from 1,000 ml of isopropanol to obtain 94.0 g of 4-methoxycarbonyloxybenzoic acid (yield: 66.2%, chemical purity:> 99%).
【0074】4−メトキシカルボニルオキシ安息香酸4
0.0gおよびジメチルホルムアミド1.50mlを脱
水クロロホルム400ml中に入れ、系を窒素置換して
おき、40℃で撹拌しながら塩化チオニル19.34m
lを滴下した。そのまま2時間撹拌した後、溶媒と過剰
の塩化チオニルをトラップを用いて留去し、さらに脱水
テトラヒドロフラン20.0mlを加えて結晶を溶解さ
せてから留去する洗浄操作を2回繰り返した。これに脱
水テトラヒドロフラン100mlを加え、さらに氷浴上
で1,2,5,6−テトラヒドロベンジルアルコール2
5.2g、トリエチルアミン22.7gおよびジメチル
アミノピリジン触媒量を脱水テトラヒドロフラン100
mlに溶解した溶液を滴下し、室温で一晩撹拌した。ト
リエチルアミン塩酸塩を濾別し、テトラヒドロフランを
2/3程度留去した後、塩化メチレン500mlで希釈
し、飽和炭酸水素ナトリウム水溶液、2モル/l塩酸、
飽和食塩水で有機相を洗い、無水硫酸マグネシウムで乾
燥し、溶媒を留去した。さらに、クロロホルムを溶媒と
したシリカゲルカラムにより精製し、4−メトキシカル
ボニルオキシ安息香酸テトラヒドロベンジルエステル5
8.8g(収率99.3%、化学純度>97%)を得
た。4-methoxycarbonyloxybenzoic acid 4
0.0 g and 1.50 ml of dimethylformamide were placed in 400 ml of dehydrated chloroform, the system was purged with nitrogen, and 19.34 ml of thionyl chloride was stirred at 40 ° C.
1 was added dropwise. After stirring for 2 hours as it was, the solvent and excess thionyl chloride were distilled off using a trap, and 20.0 ml of dehydrated tetrahydrofuran was added to dissolve the crystals, and then the washing operation of distilling off was repeated twice. To this, 100 ml of dehydrated tetrahydrofuran was added, and further, on an ice bath, 1,2,5,6-tetrahydrobenzyl alcohol 2
5.2 g, 22.7 g of triethylamine and a catalytic amount of dimethylaminopyridine were added to 100 ml of dehydrated tetrahydrofuran.
The solution dissolved in ml was added dropwise and stirred at room temperature overnight. Triethylamine hydrochloride was filtered off, and about 2/3 of tetrahydrofuran was distilled off. The residue was diluted with 500 ml of methylene chloride, and a saturated aqueous solution of sodium hydrogen carbonate, 2 mol / l hydrochloric acid,
The organic phase was washed with a saturated saline solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off. Further, it is purified by a silica gel column using chloroform as a solvent, and 4-methoxycarbonyloxybenzoic acid tetrahydrobenzyl ester 5
8.8 g (yield 99.3%, chemical purity> 97%) were obtained.
【0075】4−メトキシカルボニルオキシ安息香酸テ
トラヒドロベンジルエステル58.8g、テトラヒドロ
フラン700ml、25%アンモニア水70mlをフラ
スコに仕込み、室温で1時間撹拌した。反応液を濃塩酸
で中和し、濾過した後、溶媒を留去した。塩化メチレン
2000mlを加え、有機相を水1000mlで2回洗
った後、溶媒を留去して4−ヒドロキシ安息香酸テトラ
ヒドロベンジルエステル37.8g(収率80.4%、
化学純度>95%)を得た。58.8 g of 4-methoxycarbonyloxybenzoic acid tetrahydrobenzyl ester, 700 ml of tetrahydrofuran and 70 ml of 25% aqueous ammonia were charged into a flask and stirred at room temperature for 1 hour. After the reaction solution was neutralized with concentrated hydrochloric acid and filtered, the solvent was distilled off. After adding 2000 ml of methylene chloride and washing the organic phase twice with 1000 ml of water, the solvent was distilled off and 37.8 g of 4-hydroxybenzoic acid tetrahydrobenzyl ester (80.4% yield,
Chemical purity> 95%).
【0076】4−メトキシカルボニルオキシ安息香酸1
4.8g、4−ヒドロキシ安息香酸テトラヒドロベンジ
ルエステル18.4g、ジメチルアミノピリジン触媒量
および塩化メチレン330mlをフラスコに仕込み、撹
拌しながら、これにジシクロヘキシルカルボジイミド1
7.1gを塩化メチレン30mlに溶解した溶液を30
分かけて滴下した。そのまま室温で20分撹拌し、反応
液を濾過した後、有機相を0.5モル/l塩酸、飽和炭
酸水素ナトリウム水溶液、飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥し、溶媒を留去して、4−メトキ
シカルボニルオキシ安息香酸−p−テトラヒドロベンゾ
キシカルボニルフェニルエステル34.1g(収率>9
9%、化学純度88%)を得た。4-methoxycarbonyloxybenzoic acid 1
4.8 g, 4-hydroxybenzoic acid tetrahydrobenzyl ester 18.4 g, a catalytic amount of dimethylaminopyridine and 330 ml of methylene chloride were charged into a flask, and while stirring, dicyclohexylcarbodiimide 1 was added thereto.
30 g of a solution prepared by dissolving 7.1 g of methylene chloride in 30 ml
Dropped over minutes. After stirring at room temperature for 20 minutes as it is, the reaction solution was filtered, and the organic phase was washed with 0.5 mol / l hydrochloric acid, a saturated aqueous solution of sodium hydrogencarbonate and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off. 34.1 g of 4-methoxycarbonyloxybenzoic acid-p-tetrahydrobenzoxycarbonylphenyl ester (yield> 9)
9%, chemical purity 88%).
【0077】4−メトキシガルボニルオキシ安息香酸−
p−テトラヒドロベンゾキシカルボニルフェニルエステ
ル34.1g、テトラヒドロフラン500mlおよび2
5%アンモニア水50mlをフラスコに仕込み、室温で
1時間撹拌した。反応液を濾過し、溶媒を留去した後、
塩化メチレン500mlを加え、有機相を水500ml
で2回洗った後、無水硫酸マグネシウムで乾燥し、溶媒
を留去して4−ヒドロキシ安息香酸−p−テトラヒドロ
ベンゾキシカルボニルフェニルエステル27.7g(取
率97.1%、化学純度93%)を得た。4-methoxygarbonyloxybenzoic acid
34.1 g of p-tetrahydrobenzoxycarbonylphenyl ester, 500 ml of tetrahydrofuran and 2
50 ml of 5% aqueous ammonia was charged into the flask and stirred at room temperature for 1 hour. After the reaction solution was filtered and the solvent was distilled off,
500 ml of methylene chloride is added and the organic phase is
After drying twice with anhydrous magnesium sulfate, the solvent was distilled off, and 27.7 g of 4-hydroxybenzoic acid-p-tetrahydrobenzoxycarbonylphenyl ester was obtained (97.1% yield, 93% chemical purity). I got
【0078】4−ヒドロキシ安息香酸−p−テトラヒド
ロベンゾキシカルボニルフェニルエステル27.3g、
4−(2−プロペノイルオキシエトキシ)安息香酸1
9.2g、ジメチルアミノピリジン触媒量、ブチルヒド
ロキシトルエン(重合禁止剤)少量および塩化メチレン
500mlをフラスコに仕込み、撹拌しながら、これに
ジシクロヘキシルカルボジイミド17.6gを塩化メチ
レン30mlに溶解した溶液を30分かけて滴下した。
室温で一晩撹拌し、反応液を濾過して塩化メチレン50
0mlを加えて希釈した後、有機相を0.5モル/l塩
酸、飽和炭酸水素ナトリウム水溶液、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥させ、溶媒を留去し
た。イソプロパノール700mlから再結晶し、架橋型
ネマチック性液晶モノマー24.6g(収率56%、化
学純度99%)を得た。27.3 g of 4-hydroxybenzoic acid-p-tetrahydrobenzoxycarbonylphenyl ester,
4- (2-propenoyloxyethoxy) benzoic acid 1
9.2 g, a catalyst amount of dimethylaminopyridine, a small amount of butylhydroxytoluene (polymerization inhibitor) and 500 ml of methylene chloride were charged into a flask, and a solution obtained by dissolving 17.6 g of dicyclohexylcarbodiimide in 30 ml of methylene chloride was stirred for 30 minutes. It dripped over.
Stir at room temperature overnight, filter the reaction and filter
After dilution by adding 0 ml, the organic phase was washed with 0.5 mol / l hydrochloric acid, a saturated aqueous solution of sodium bicarbonate and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off. Recrystallization from 700 ml of isopropanol gave 24.6 g of a crosslinked nematic liquid crystal monomer (yield 56%, chemical purity 99%).
【0079】製造例3(架橋型ネマチック性液晶ポリマ
ー(a)の合成)Production Example 3 (Synthesis of Crosslinked Nematic Liquid Crystal Polymer (a))
【化27】 製造例1で得たネマチック性液晶モノマー5.00g、
製造例2で得た架橋型ネマチック性液晶モノマー0.5
19gおよびジメチルアセトアミド/テトラヒドロフラ
ン=4/1(重量比)の混合溶媒50mlをフラスコに
仕込み、系内を窒素置換した。水浴上で、溶液を温度5
7℃に加温して前記液晶モノマーを溶解させた後、アゾ
ビスイソブチロニトリル0.106gをジメチルアセト
アミド/テトラヒドロフラン=4/1(重量比)の混合
溶媒2mlに溶解した溶液を滴下した。溶液温度57℃
に加温したまま、窒素置換しなから6時間撹拌し、室温
まで放冷した後、反応液を濾過し、メタノール1000
mlに投入してポリマーを析出させた。ポリマーを濾取
し、メタノール/テトラヒドロフラン=3 /2(重量
比)の混合溶媒で洗浄し、減圧乾燥して目的の架橋型ネ
マチック性液晶ポリマー4.78g(収率87%、重量
平均分子量10000)を得た。なお、化27中のポリ
マーは便宜的にブロック共重合体で表し、繰り返し単位
の下にそれぞれの共重合割合(モル%)を示した。Embedded image 5.00 g of the nematic liquid crystal monomer obtained in Production Example 1,
Crosslinkable nematic liquid crystal monomer 0.5 obtained in Production Example 2
19 g and 50 ml of a mixed solvent of dimethylacetamide / tetrahydrofuran = 4/1 (weight ratio) were charged into a flask, and the system was purged with nitrogen. On a water bath, bring the solution to a temperature of 5
After heating to 7 ° C. to dissolve the liquid crystal monomer, a solution prepared by dissolving 0.106 g of azobisisobutyronitrile in 2 ml of a mixed solvent of dimethylacetamide / tetrahydrofuran = 4/1 (weight ratio) was added dropwise. Solution temperature 57 ° C
The mixture was stirred for 6 hours while being purged with nitrogen, and allowed to cool to room temperature.
The polymer was precipitated by charging the solution into the ml. The polymer was collected by filtration, washed with a mixed solvent of methanol / tetrahydrofuran = 3/2 (weight ratio), dried under reduced pressure, and 4.78 g of the desired crosslinked nematic liquid crystal polymer (87% yield, weight average molecular weight 10,000). I got In addition, the polymer in Chemical formula 27 is conveniently represented by a block copolymer, and the copolymerization ratio (mol%) is shown below the repeating unit.
【0080】製造例4(コレステリック性を付与するモ
ノマー(b1)の合成)Production Example 4 (Synthesis of monomer (b1) imparting cholesteric properties)
【化28】 イソソルビド10.0gおよびp−トルエンスルホン酸
をテトラヒドロフラン100ml中に入れ、室温で撹拌
しなからジビドロピラン5.76gをテトラヒドロフラ
ン50mlに溶解させた溶液を1.5時問かけて滴下し
た。そのまま室温で1.5時間撹拌した後、溶媒を留去
し、塩化メチレン250mlに溶解させて、1モル/l
塩酸、飽和炭酸水素ナトリウム水溶液、飽和食塩水で洗
浄し、有機相を無水硫酸マグネシウムで乾燥した。溶媒
を留去し、塩化メチレン/ジエチルエーテル=1/1
(重量比)を展開溶媒としたシリカゲルカラムクロマト
により精製して、ジヒドロピランの水酸基の片側を保護
した化合物4.79g(収率30%)を得た。Embedded image 10.0 g of isosorbide and p-toluenesulfonic acid were placed in 100 ml of tetrahydrofuran, and while stirring at room temperature, a solution of 5.76 g of dividropyran dissolved in 50 ml of tetrahydrofuran was added dropwise over 1.5 hours. After stirring at room temperature for 1.5 hours, the solvent was distilled off and dissolved in 250 ml of methylene chloride to give 1 mol / l.
The extract was washed with hydrochloric acid, a saturated aqueous solution of sodium hydrogen carbonate and saturated saline, and the organic phase was dried over anhydrous magnesium sulfate. The solvent was distilled off, and methylene chloride / diethyl ether = 1/1
Purification by silica gel column chromatography using (weight ratio) as a developing solvent gave 4.79 g (yield 30%) of a compound in which one side of a hydroxyl group of dihydropyran was protected.
【0081】次に、水酸基を片側保護したイソソルビド
4. 21g、p−シアノ安息香酸2. 96g、ジメチル
アミノピリジン触媒量および酢酸エチル110mlをフ
ラスコに仕込み、これに、撹拌しなからジシクロヘキシ
ルカルボジイミド4.52gを酢酸エチル5mlに溶解
させた溶液を滴下した。室温で2時間撹拌し、濾過、酢
酸エチル50mlで希釈した後、1モル/l塩酸、飽和
炭酸水素ナトリウム水溶液、飽和食塩水で洗浄し、有機
相を無水硫酸マグネシウムで乾燥した。溶媒を留去し
て、片側水酸基保護イソソルビドのシアノフェニルエス
テル(化学純度83%)を得た。Next, 4.21 g of isosorbide having a hydroxyl group protected on one side, 2.96 g of p-cyanobenzoic acid, a catalytic amount of dimethylaminopyridine and 110 ml of ethyl acetate were charged into a flask, and while stirring, dicyclohexylcarbodiimide was added to the flask. A solution in which 52 g was dissolved in 5 ml of ethyl acetate was added dropwise. The mixture was stirred at room temperature for 2 hours, filtered, diluted with 50 ml of ethyl acetate, washed with 1 mol / l hydrochloric acid, a saturated aqueous solution of sodium bicarbonate and brine, and the organic phase was dried over anhydrous magnesium sulfate. The solvent was distilled off to obtain a cyanophenyl ester of isosorbide having a hydroxyl group protected on one side (chemical purity: 83%).
【0082】片側水酸基保護イソソルビドのシアノフェ
ニルエステル7.44gをテトラヒドロフラン75ml
に溶解させて還流し、濃塩酸3mlを滴下してさらに1
5分還流した。テトラヒドロフランを留去し、塩化メチ
レン200mlに溶解させて、有機相を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥した。展開溶媒とし
て塩化メチレン/ジエチルエーテル=6/1〜0/1
(重量比)と変化させなからシリカゲルカラムクロマト
により精製し、水酸基の保護基を外したイソソルビドの
シアノフェニルエステル4.63g(収率91%、化学
純度97%)を得た。7.44 g of a cyanophenyl ester of isosorbide protected with one hydroxyl group was added to 75 ml of tetrahydrofuran.
, And refluxed.
Refluxed for 5 minutes. The tetrahydrofuran was distilled off, the residue was dissolved in 200 ml of methylene chloride, and the organic phase was washed with saturated saline and dried over anhydrous magnesium sulfate. Methylene chloride / diethyl ether = 6/1 to 0/1 as a developing solvent
(Weight ratio), purification was carried out by silica gel column chromatography to obtain 4.63 g (yield 91%, chemical purity 97%) of cyanophenyl ester of isosorbide from which the hydroxyl-protecting group was removed.
【0083】4−(2−プロペノイルオキシエトキシ)
安息香酸2.55g、イソソルビドのシアノフェニルエ
ステル2.83g、ジメチルアミノピリジン触媒量およ
び塩化メチレン70mlをフラスコに仕込み、室温で撹
絆しながらジシクロヘキシルカルボジイミド2.33g
を塩化メチレン5mlに溶解させた溶液を滴下した。そ
のまま4. 5時間撹拌し、濾過、塩化メチレン130m
lで希釈した後、1モル/l塩酸、飽和炭酸水素ナトリ
ウム水溶液、飽和食塩水で有機相を洗浄し、無水硫酸マ
グネシウムで乾燥した。溶媒を留去し、塩化メチレン/
ジエチルエーテル=6/1(重量比)を展開溶媒とした
シリカゲルカラムクロマトにより精製し、目的のコレス
テリック性を付与するモノマー1.39g(収率23
%、化学純度90%)を得た。4- (2-propenoyloxyethoxy)
2.55 g of benzoic acid, 2.83 g of cyanophenyl ester of isosorbide, a catalytic amount of dimethylaminopyridine and 70 ml of methylene chloride are charged into a flask, and 2.33 g of dicyclohexylcarbodiimide is stirred at room temperature while stirring.
Was dissolved in 5 ml of methylene chloride. The mixture was stirred for 4.5 hours, filtered, and methylene chloride (130 m)
After diluting with 1 l, the organic phase was washed with 1 mol / l hydrochloric acid, saturated aqueous sodium hydrogen carbonate solution and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off, and methylene chloride /
Purified by silica gel column chromatography using diethyl ether = 6/1 (weight ratio) as a developing solvent, 1.39 g of a monomer to give a desired cholesteric property (yield: 23)
%, Chemical purity 90%).
【0084】製造例5(架橋型ネマチック性液晶モノマ
ー(b2)の合成)Production Example 5 (Synthesis of crosslinked nematic liquid crystal monomer (b2))
【化29】 4,4−ビフェノール200g、濃塩酸少量およびテト
ラヒドロフラン2Lをフラスコに仕込み、攪拌しながら
3,4−ジヒドロ−2H−ピラン90.3gを滴下し
た。そのまま、2時間攪拌し、反応液にトリエチルアミ
ンを加えてpH8程度に調整した後、テトラヒドロフラ
ンを4/5程度留去した。これに塩化メチレン2Lおよ
び2モル/lの水酸化ナトリウム水溶液2Lを加えて攪
拌し、析出した結晶を濾取した。この結晶を塩化メチレ
ン2L中に入れ、攪拌しながら酢酸30mlを加えてp
H4程度に調整し、有機相を飽和炭酸水素ナトリウム水
溶液、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後、溶媒を留去して、水酸基の片側を保護したビフェ
ノール104gを得た(収率35%,化学純度99
%)。Embedded image 200 g of 4,4-biphenol, a small amount of concentrated hydrochloric acid and 2 L of tetrahydrofuran were charged into a flask, and 90.3 g of 3,4-dihydro-2H-pyran was added dropwise with stirring. The mixture was stirred for 2 hours as it was, and the reaction solution was adjusted to about pH 8 by adding triethylamine, and tetrahydrofuran was distilled off about 4/5. 2 L of methylene chloride and 2 L of a 2 mol / l aqueous sodium hydroxide solution were added thereto, followed by stirring, and the precipitated crystals were collected by filtration. The crystals are placed in 2 L of methylene chloride, and 30 ml of acetic acid is added thereto while stirring.
The pH was adjusted to about H4, and the organic phase was washed with a saturated aqueous solution of sodium hydrogencarbonate and saturated saline, dried over anhydrous magnesium sulfate, and then the solvent was distilled off to obtain 104 g of biphenol in which one side of a hydroxyl group was protected (yield). 35%, chemical purity 99
%).
【0085】4−(2−プロペノイルオキシエトキシ)
安息香酸2.55g、水酸基の片側を保護したビフェノ
ール2.92g、ジメチルアミノピリジン触媒量および
塩化メチレン60mlをフラスコに仕込み、室温で撹拌
しながら、これにジシクロヘキシルカルボジイミド2.
33gを塩化メチレン5mlに溶解した溶液を滴下し
た。そのまま16時間攪拌し、反応液を濾過して塩化メ
チレン130mlを加えて希釈した後、有機相を1モル
/l塩酸、飽和炭酸水素ナトリウム水溶液、飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥させ、溶媒を留
去した。イソプロパノール100mlから再結晶し、水
酸基を保護した液晶モノマーの前駆体4.80g(収率
88%、化学純度98%)を得た。4- (2-propenoyloxyethoxy)
2.55 g of benzoic acid, 2.92 g of biphenol protected on one side of the hydroxyl group, a catalytic amount of dimethylaminopyridine and 60 ml of methylene chloride were charged into a flask, and stirred at room temperature while dicyclohexylcarbodiimide was added.
A solution of 33 g dissolved in 5 ml of methylene chloride was added dropwise. After stirring for 16 hours, the reaction solution was filtered and diluted by adding 130 ml of methylene chloride, and the organic phase was washed with 1 mol / l hydrochloric acid, a saturated aqueous solution of sodium hydrogen carbonate and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off. The crystal was recrystallized from 100 ml of isopropanol to obtain 4.80 g (88% yield, 98% chemical purity) of a hydroxy-protected liquid crystal monomer precursor.
【0086】水酸基を保護した液晶モノマーの前駆体
3.00gをテトラヒドロフラン45mlに溶解し、濃
塩酸1mlを加えて1時間加熱還流した。室温まで冷却
した後、トラップを用いてテトラヒドロフランと過剰の
塩酸を留去し、テトラヒドロフラン30mlを加えて残
留した固形分を溶解させて溶媒を留去する洗浄操作を3
回繰り返し、固形分を減圧乾燥して、水酸基の保護基を
外した液晶モノマーの前駆体2.45gを得た。[0086] 3.00 g of a liquid crystal monomer precursor having a protected hydroxyl group was dissolved in 45 ml of tetrahydrofuran, and 1 ml of concentrated hydrochloric acid was added thereto, followed by heating under reflux for 1 hour. After cooling to room temperature, tetrahydrofuran and excess hydrochloric acid were distilled off using a trap, and 30 ml of tetrahydrofuran was added to dissolve the remaining solids and the solvent was distilled off.
The solid content was dried under reduced pressure to obtain 2.45 g of a liquid crystal monomer precursor from which a hydroxyl-protecting group had been removed.
【0087】液晶モノマーの前駆体2.00g、1,
2,5,6−テトラヒドロ安息香酸0.624g、ジメ
チルアミノピリジン触媒量および少量のブチルヒドロキ
シトルエン(重合禁止剤)および塩化メチレン30ml
をフラスコに仕込み、攪拌しながらジシクロヘキシルカ
ルボジイミド1.12gを塩化メチレン2 mlに溶解し
た溶液を滴下した。そのまま16時間攪拌し、反応液を
濾過して塩化メチレン100mlを加えて希釈した後、
有機相を0.5モル/l塩酸、飽和炭酸水素ナトリウム
水溶液、飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥させ、溶媒を留去した。イソプロパノール30ml
から再結晶し、架橋型ネマチック性液晶モノマー2.0
5g(収率81%、化学純度96%)を得た。2.00 g of a liquid crystal monomer precursor,
0.624 g of 2,5,6-tetrahydrobenzoic acid, dimethylaminopyridine catalyst amount and a small amount of butylhydroxytoluene (polymerization inhibitor) and methylene chloride 30 ml
Was charged into a flask, and a solution of 1.12 g of dicyclohexylcarbodiimide dissolved in 2 ml of methylene chloride was added dropwise with stirring. After stirring for 16 hours, the reaction solution was filtered and diluted by adding 100 ml of methylene chloride.
The organic phase was washed with 0.5 mol / l hydrochloric acid, a saturated aqueous solution of sodium hydrogen carbonate, and saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off. 30 ml of isopropanol
From the crosslinked nematic liquid crystal monomer 2.0
5 g (yield 81%, chemical purity 96%) were obtained.
【0088】製造例6(架橋型コレステリック性液晶ポ
リマー(b)の合成)Production Example 6 (Synthesis of crosslinked cholesteric liquid crystal polymer (b))
【化30】 製造例4で得たコレステリック性を付与するモノマー
5.00g、製造例5で得た架橋型ネマチック性液晶モ
ノマー0.391gおよびジメチルアセトアミド/テト
ラヒドロフラン=4/1(重量比)の混合溶媒50ml
をフラスコに仕込み、系内を窒素置換した。水浴上で溶
液温度57℃に加温して前記液晶モノマーを溶解させた
後、アゾビスイソブチロニトリル0.0895gをジメ
チルアセトアミド/テトラヒドロフラン=4/1(重量
比)の混合溶媒2mlに溶解した溶液を滴下した。溶液
温度57℃に加温したまま、窒素置換しながら6時間撹
拌し、室温まで放冷した後、反応液を濾過し、メタノー
ル1000mlに投入してポリマーを析出させた。ポリ
マーを濾取し、メタノール/テトラヒドロフラン=3/
2(重量比)の混合溶媒で洗浄し、減圧乾燥して目的の
架橋型コレステリック性液晶ポリマー4.69g(収率
87%、重量平均分子量10000)を得た。なお、化
30中のポリマーは便宜的にブロック共重合体で表し、
繰り返し単位の下にそれぞれの共重合割合(モル%)を
示した。Embedded image 5.00 g of the monomer imparting cholesteric properties obtained in Production Example 4, 0.391 g of the crosslinked nematic liquid crystal monomer obtained in Production Example 5, and 50 ml of a mixed solvent of dimethylacetamide / tetrahydrofuran = 4/1 (weight ratio)
Was charged into a flask, and the atmosphere in the system was replaced with nitrogen. After heating to a solution temperature of 57 ° C. on a water bath to dissolve the liquid crystal monomer, 0.0895 g of azobisisobutyronitrile was dissolved in 2 ml of a mixed solvent of dimethylacetamide / tetrahydrofuran = 4/1 (weight ratio). The solution was added dropwise. The mixture was stirred for 6 hours while being replaced with nitrogen while being heated to a solution temperature of 57 ° C., and allowed to cool to room temperature. Then, the reaction solution was filtered and poured into 1,000 ml of methanol to precipitate a polymer. The polymer was collected by filtration, and methanol / tetrahydrofuran = 3 /
After washing with a 2 (weight ratio) mixed solvent and drying under reduced pressure, 4.69 g (yield 87%, weight average molecular weight 10,000) of the desired crosslinked cholesteric liquid crystal polymer was obtained. In addition, the polymer in Chemical formula 30 is conveniently represented by a block copolymer,
The copolymerization ratio (mol%) is shown below the repeating unit.
【0089】製造例7(コレステリック性を付与するモ
ノマー(c)の合成)Production Example 7 (Synthesis of monomer (c) imparting cholesteric properties)
【化31】 p−ヒドロキシベンズアルデビド122gをトルエン1
200mlに加温して溶解した後、(S)−(−)−1
−フェニルエチルアミン121gを30分かけて加え、
Dean−Stark器を用いて理論量の水を確認する
まで約3〜4時間還流した。次に反応液を放冷し、析出
した結晶を濾過し、エタノール1500mlで再結晶し
て自色の針状結晶(キラルフェノール化合物)166g
が得られた。Embedded image 122 g of p-hydroxybenzaldevide was added to toluene 1
After heating and dissolving in 200 ml, (S)-(-)-1
121 g of phenylethylamine are added over 30 minutes,
Reflux for about 3-4 hours until the theoretical amount of water is confirmed using a Dean-Stark apparatus. Next, the reaction solution was allowed to cool, and the precipitated crystals were filtered and recrystallized with 1500 ml of ethanol to obtain 166 g of self-colored needle-like crystals (chiral phenol compound).
was gotten.
【0090】4−(2−プロペノイルオキシエトキシ)
安息香酸118g、キラルフェノール化合物113g、
ジメチルアミノピリジン触媒量およびブチルヒドロキシ
トルエン少量を酢酸エチル2500mlに溶解し、室温
撹拌を行い、そこへ酢酸エチル200mlに溶解したジ
シクロヘキシルカルボジイミド(DCC)124gを徐
々に添加した。室温で5時問撹拌した後、析出したDC
Cウレアを濾別した。濾液を飽和炭酸水素ナトリウム水
溶液、飽和食塩水(2回)(各100ml)で洗浄し、
さらに硫酸マグネシウムで乾燥、濾別、溶媒を留去した
後、エタノール1800mlで再結晶を行い、目的のコ
レステリック性を付与するモノマー130g(化学純度
>90%)を得た。4- (2-propenoyloxyethoxy)
Benzoic acid 118 g, chiral phenol compound 113 g,
A catalyst amount of dimethylaminopyridine and a small amount of butylhydroxytoluene were dissolved in 2500 ml of ethyl acetate, stirred at room temperature, and 124 g of dicyclohexylcarbodiimide (DCC) dissolved in 200 ml of ethyl acetate was gradually added thereto. After stirring at room temperature for 5 hours, the deposited DC
C urea was filtered off. The filtrate was washed with a saturated aqueous sodium hydrogen carbonate solution and saturated saline (twice) (100 ml each),
Further, after drying over magnesium sulfate, filtration and removal of the solvent, the residue was recrystallized with 1800 ml of ethanol to obtain 130 g of a monomer having a desired cholesteric property (chemical purity> 90%).
【0091】比較製造例1 製造例3において、製造例2で得た架橋型ネマチック性
液晶モノマーを用いなかったこと以外は、製造例3と同
様の重合を行い、ネマチック性液晶ポリマー(重量平均
分子量10000)を得た。Comparative Production Example 1 The same polymerization as in Production Example 3 was carried out except that the crosslinked nematic liquid crystal monomer obtained in Production Example 2 was not used, and the nematic liquid crystal polymer (weight average molecular weight) was used. 10,000).
【0092】実施例1 製造例3で得られた架橋型ネマチック性液晶ポリマー1
00重量部、製造例6で得られた架橋型コレステリック
性液晶ポリマー13重量部および製造例7で得られたコ
レステリック性を付与するモノマー21重量部をシクロ
ヘキサノンに溶解させて30重量%の液晶組成物の溶液
を調製した。Example 1 Cross-linked nematic liquid crystal polymer 1 obtained in Production Example 3
00 parts by weight, 13 parts by weight of the crosslinked cholesteric liquid crystal polymer obtained in Production Example 6 and 21 parts by weight of the cholestericity-imparting monomer obtained in Production Example 7 are dissolved in cyclohexanone to obtain a 30% by weight liquid crystal composition. Was prepared.
【0093】次に、ガラス板上にポリビニルアルコール
水溶液をスピンコートにより塗布し、170℃で1時間
乾燥させて厚み0.1μmの薄膜を形成し、これをレー
ヨン布で一定方向に擦ってラビング処理した配向板を用
意した。Next, a polyvinyl alcohol aqueous solution is applied on a glass plate by spin coating, and dried at 170 ° C. for 1 hour to form a 0.1 μm-thick thin film. A prepared alignment plate was prepared.
【0094】この配向板上に、前記液晶組成物の溶液
を、スピンコーターにて塗布して乾燥させ、160℃で
5分間加熱して配向処理後に、室温にて放冷した後、電
子線を40Mrad/cm2 で照射して架橋し、配向架
橋処理された配向フィルムを得た。On the alignment plate, the solution of the liquid crystal composition was applied by a spin coater, dried, heated at 160 ° C. for 5 minutes, subjected to alignment treatment, allowed to cool at room temperature, and then irradiated with an electron beam. Irradiation was carried out at 40 Mrad / cm 2 to crosslink, and an oriented film subjected to orientation crosslinking treatment was obtained.
【0095】実施例2 実施例1で調製した液晶組成物100重量部を含む溶液
に、光酸発生剤5重量部を添加した液晶組成物の溶液を
調製し、さらに当該溶液に実施例1と同様の配向処理を
行った後、透過率が100%、50%、0%の3領域を
100μmピッチで有するフォトマスクを介してDee
p紫外線を100mJ/cm2 照射し、さらに前記同様
の配向処理条件で再配向して多色反射処理を行った後、
電子線を40Mrad/cm2 で照射して架橋処理し
て、配向架橋処理された配向フィルム(多色反射板)を
得た。得られた多色反射板は、中心波長について、反射
光の中心が450nm、540nm、620nmの3領
域を有していた。Example 2 To a solution containing 100 parts by weight of the liquid crystal composition prepared in Example 1 was added a solution of a liquid crystal composition in which 5 parts by weight of a photoacid generator was added. After performing the same alignment treatment, the Dee is passed through a photomask having three regions having transmittances of 100%, 50%, and 0% at a pitch of 100 μm.
After irradiation with p-ultraviolet light at 100 mJ / cm 2 , and re-orientation under the same orientation treatment conditions as described above and performing multicolor reflection treatment,
An electron beam was irradiated at 40 Mrad / cm 2 to perform a cross-linking treatment, thereby obtaining an oriented film (a multicolor reflector) subjected to an orientation-cross-linking treatment. The resulting multicolor reflector had three regions of 450 nm, 540 nm, and 620 nm at the center of the reflected light with respect to the center wavelength.
【0096】比較例l 実施例1において、製造例3で得られた架橋型ネマチッ
ク性液晶ポリマーの代わりに比較製造例1で得られたネ
マチック性液晶ポリマーを用いた以外は実施例1と同様
の操作を行い配向フィルムを得た。Comparative Example 1 The procedure of Example 1 was repeated, except that the nematic liquid crystal polymer obtained in Comparative Production Example 1 was used instead of the crosslinked nematic liquid crystal polymer obtained in Production Example 3. The operation was performed to obtain an oriented film.
【0097】比較例2 実施例1において、製造例6で得られたコレステリック
性を付与するモノマーを用いることなく液晶組成物を調
製した以外は、実施例1と同様の操作を行い配向フィル
ムを得た。Comparative Example 2 An alignment film was obtained in the same manner as in Example 1, except that the liquid crystal composition was prepared without using the cholestericity-imparting monomer obtained in Production Example 6. Was.
【0098】比較例3 実施例2において、製造例3で得られた架橋型ネマチッ
ク性液晶ポリマーの代わりに比較製造例1で得られたネ
マチック性液晶ポリマーを用いた以外は実施例2と同様
の操作を行い配向フィルムを得た。Comparative Example 3 The same procedure as in Example 2 was carried out except that the nematic liquid crystal polymer obtained in Comparative Production Example 1 was used instead of the crosslinked nematic liquid crystal polymer obtained in Production Example 3. The operation was performed to obtain an oriented film.
【0099】比較例4 実施例2において、製造例7で得られたコレステリック
性を付与するモノマーを用いることなく液晶組成物を調
製した以外は、実施例2と同様の操作を行い配向フィル
ムを得た。Comparative Example 4 An alignment film was obtained in the same manner as in Example 2 except that the liquid crystal composition was prepared without using the monomer imparting cholesteric properties obtained in Production Example 7. Was.
【0100】参考例1 実施例1において、電子線照射を行わないこと以外は、
実施例1と同様の操作を行い配向フィルムを得た。Reference Example 1 In Example 1, except that the electron beam irradiation was not performed,
The same operation as in Example 1 was performed to obtain an oriented film.
【0101】参考例2 実施例2において、電子線照射を行わないこと以外は、
実施例2と同様の操作を行い配向フィルムを得た。Reference Example 2 In Example 2, except that electron beam irradiation was not performed,
The same operation as in Example 2 was performed to obtain an oriented film.
【0102】実施例、比較例で得た配向フィルムを種々
の温度で1時間加熱して外観の変化を目視観察し、変化
が認められない最高温度を耐熱温度として評価した。結
果を表1に示す。The oriented films obtained in Examples and Comparative Examples were heated at various temperatures for 1 hour, and changes in appearance were visually observed. The highest temperature at which no change was observed was evaluated as the heat resistant temperature. Table 1 shows the results.
【0103】[0103]
【表1】 表1より、架橋型ネマチック性液晶ポリマー(a)、架
橋型コレステリック性液晶ポリマー(b)およびコレス
テリック性を付与するモノマー(c)を含有する液晶組
成物から調製された実施例の配向フィルムは、これらの
一方を含有していない液晶組成物から得られた比較例の
配向フィルムに比べて、耐熱温度が大幅に向上している
ことが認められる。また、参考例から、配向フィルム
は、架橋処理を施すことにより、耐熱温度が大幅に向上
していることが認められる。[Table 1] From Table 1, the alignment film of the example prepared from the liquid crystal composition containing the cross-linked nematic liquid crystal polymer (a), the cross-linked cholesteric liquid crystal polymer (b) and the monomer (c) for imparting cholesteric property is as follows: It can be seen that the heat resistance temperature is significantly improved as compared with the alignment film of the comparative example obtained from the liquid crystal composition not containing one of these. Further, from the reference example, it is recognized that the heat resistance temperature of the oriented film is significantly improved by performing the crosslinking treatment.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) G02B 5/20 101 G02B 5/20 101 4J002 5/30 5/30 4J011 G02F 1/13 505 G02F 1/13 505 4J027 1/1335 520 1/1335 520 1/13363 1/13363 (72)発明者 中西 貞裕 大阪府茨木市下穂積1丁目1番2号 日東 電工株式会社内 (72)発明者 望月 周 大阪府茨木市下穂積1丁目1番2号 日東 電工株式会社内 Fターム(参考) 2H048 AA06 AA09 AA12 AA19 AA22 BA04 BA64 BB02 BB14 BB42 2H049 BA03 BA06 BA46 BB43 BC04 BC09 BC22 2H088 GA02 GA03 HA15 HA21 JA14 MA20 2H091 HA11 LA15 LA30 4H027 BA02 BA13 BD01 4J002 BG07W BG07X EH076 FD146 4J011 AC04 QA03 QA33 QA38 QA44 QA45 QA46 QB02 QB03 UA01 UA03 UA06 VA01 WA10 4J027 AA01 AA02 CC03 CD04 CD05──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification code FI Theme coat ゛ (Reference) G02B 5/20 101 G02B 5/20 101 4J002 5/30 5/30 4J011 G02F 1/13 505 G02F 1/13 505 4J027 1/1335 520 1/1335 520 1/13363 1/13363 (72) Inventor Sadahiro Nakanishi 1-2-1, Shimohozumi, Ibaraki-shi, Osaka Nitto Denko Corporation (72) Inventor Shu Mochizuki Ibaraki, Osaka 1-1-2 Shimohozumi Ichito F-term in Nitto Denko Corporation (reference) 2H048 AA06 AA09 AA12 AA19 AA22 BA04 BA64 BB02 BB14 BB42 2H049 BA03 BA06 BA46 BB43 BC04 BC09 BC22 2H088 GA02 GA03 HA15 HA21 JA14 MA20 LA027 HA11 BA02 BA13 BD01 4J002 BG07W BG07X EH076 FD146 4J011 AC04 QA03 QA33 QA38 QA44 QA45 QA46 QB02 QB03 UA01 UA03 UA06 VA01 WA10 4J027 AA01 AA02 CC03 CD04 CD05
Claims (8)
はそれぞれ独立して環状系官能基を、Xは−COO−
基、−OCO−基または−O−基を、Eはシアノ基、ア
ルキル基、アルコキシ基、ヒドロキシ基、塩素原子また
はフッ素原子を、gは2〜6の整数を示す。)で表され
る繰り返し単位、および、一般式(a2): 【化2】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xはそれぞれ独立
して−COO−基、−OCO−基または−O−基を、G
は架橋基を、hは2〜6の整数を、kは0〜6の整数を
示す。)で表される繰り返し単位を有する架橋型ネマチ
ック性液晶ポリマー(a)、一般式(b1): 【化3】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xはそれぞれ独立
して−COO−基、−OCO−基または−O−基を、L
は活性光線により変性ないし失活しない光学活性基を、
Eはシアノ基、アルキル基、アルコキシ基、ヒドロキシ
基、塩素原子またはフッ素原子を、rは2〜6の整数を
示す。)で表される繰り返し単位、および、一般式(b
2): 【化4】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xはそれぞれ独立
して−COO−基、−OCO−基または−O−基を、G
は架橋基を、hは2〜6の整数を、kは0〜6の整数を
示す。)で表される繰り返し単位を有する架橋型コレス
テリック性液晶ポリマー(b)、ならびに、一般式
(c): 【化5】 (式中、R1 は水素原子またはメチル基を、AおよびD
はそれぞれ独立して環状系官能基を、Xは−COO−
基、−OCO−基または−O−基を、Jは活性光線によ
り変性ないし失活する光学活性基を、wは2〜6の整数
を示す。)で表されるコレステリック性を付与するモノ
マー(c)を含有してなるコレステリック性液晶組成
物。1. General formula (a1): (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group, and X represents -COO-
A group, —OCO— or —O—, E represents a cyano group, an alkyl group, an alkoxy group, a hydroxy group, a chlorine atom or a fluorine atom, and g represents an integer of 2 to 6. And a repeating unit represented by the general formula (a2): (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group; X each independently represents a -COO- group, -OCO- group or -O- group;
Represents a crosslinking group, h represents an integer of 2 to 6, and k represents an integer of 0 to 6. A) a cross-linked nematic liquid crystal polymer having a repeating unit represented by formula (a), and a general formula (b1): (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group; X each independently represents a -COO- group, -OCO- group or -O- group;
Is an optically active group that is not modified or deactivated by actinic light,
E represents a cyano group, an alkyl group, an alkoxy group, a hydroxy group, a chlorine atom or a fluorine atom, and r represents an integer of 2 to 6. ) And a general formula (b)
2): embedded image (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group; X each independently represents a -COO- group, -OCO- group or -O- group;
Represents a crosslinking group, h represents an integer of 2 to 6, and k represents an integer of 0 to 6. A) a cross-linked cholesteric liquid crystal polymer having a repeating unit represented by formula (b), and a general formula (c): (Wherein R 1 represents a hydrogen atom or a methyl group, A and D
Each independently represents a cyclic functional group, and X represents -COO-
A group, -OCO- group or -O- group, J represents an optically active group which is modified or deactivated by actinic rays, and w represents an integer of 2-6. A cholesteric liquid crystal composition containing a monomer (c) for imparting cholesteric properties represented by the formula (1).
式(b1)、一般式(b2)、一般式(c)におけるA
およびD(環状系官能基)が、一般式: 【化6】 で表される環状系官能基のいずれかであることを特徴と
する請求項1に記載のコレステリック性液晶組成物。2. A in the general formulas (a1), (a2), (b1), (b2) and (c)
And D (cyclic functional group) are represented by the general formula: The cholesteric liquid crystal composition according to claim 1, which is any one of the cyclic functional groups represented by
るG(架橋基)が、一般式: 【化7】 (式中、R1 は水素原子またはメチル基を示す)で表さ
れる架橋基のいずれかであることを特徴とする請求項1
または2記載のコレステリック性液晶組成物。3. G (crosslinking group) in the general formulas (a2) and (b2) is represented by the following general formula: ( 1 ) wherein R 1 represents a hydrogen atom or a methyl group;
Or the cholesteric liquid crystal composition according to 2.
より変性ないし失活しない光学活性基)が、一般式: 【化8】 (各式中、t,uは、0≦t≦5、1≦u≦6、かつt
+1≦uを満足する整数を示す。)で表される光学活性
基(l)のいずれかであることを特徴とする請求項1〜
3のいずれかに記載のコレステリック性液晶組成物。4. In the general formula (b1), L (an optically active group which is not modified or deactivated by actinic rays) is represented by the general formula: (In each formula, t and u are 0 ≦ t ≦ 5, 1 ≦ u ≦ 6, and t
Indicates an integer satisfying + 1 ≦ u. The optically active group (l) represented by the formula (1):
3. The cholesteric liquid crystal composition according to any one of 3.
り変性ないし失活する光学活性基)が、一般式: 【化9】 (各式中、R2 はフェニル基、ビフェニル基、1−ナフ
チル基または2−ナフチル基を示し、R3 はメチル基、
フェニル基またはカルボキシメチル基を示し、R 4 はメ
チル基、ベンジル基またはt−ブチル基を示す。*は不
斉炭素原子を示す。)で表される光学活性基(l)のい
ずれかであることを特徴とする請求項1〜4のいずれか
に記載のコレステリック性液晶組成物。5. The method according to claim 1, wherein J in the general formula (c) is
An optically active group which is modified or deactivated) has the general formula:(In each formula, RTwo Represents a phenyl group, a biphenyl group, 1-naph
A tyl group or a 2-naphthyl group;Three Is a methyl group,
A phenyl group or a carboxymethyl group; Four Hame
It represents a tyl group, a benzyl group or a t-butyl group. * Is not
Shows asymmetric carbon atoms. The optically active group (l) represented by
5. Any of claims 1 to 4, wherein
3. The cholesteric liquid crystal composition according to item 1.
テリック性液晶組成物に配向処理および架橋処理を施し
て得られる配向フィルム。6. An alignment film obtained by subjecting the cholesteric liquid crystal composition according to claim 1 to an alignment treatment and a crosslinking treatment.
テリック性液晶組成物に、複数の領域ごとに制御された
活性光線を順次又は同時に照射して、当該コレステリッ
ク性液晶組成物中の光学活性基の有効含有量が異なる複
数の領域を形成し、その後又はそれと同時にコレステリ
ック性液晶組成物を配向処理して前記領域ごとに反射波
長の異なる反射領域を形成する多色化処理工程を行った
後、さらに架橋処理を施す多色反射板の製造方法。7. The cholesteric liquid crystal composition according to claim 1, wherein the cholesteric liquid crystal composition is irradiated with actinic rays controlled for each of a plurality of regions sequentially or simultaneously. A plurality of regions having different effective contents of active groups were formed, and thereafter, or simultaneously, a cholesteric liquid crystal composition was subjected to an alignment treatment to form a reflection region having a different reflection wavelength for each of the regions. Thereafter, a method for producing a multicolor reflector, which is further subjected to a crosslinking treatment.
色反射板。8. A multicolor reflector obtained by the method according to claim 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000147230A JP2001323125A (en) | 2000-05-19 | 2000-05-19 | Cholesteric liquid crystal composition, oriented film and multicolor reflective plate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000147230A JP2001323125A (en) | 2000-05-19 | 2000-05-19 | Cholesteric liquid crystal composition, oriented film and multicolor reflective plate |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001323125A true JP2001323125A (en) | 2001-11-20 |
Family
ID=18653438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000147230A Pending JP2001323125A (en) | 2000-05-19 | 2000-05-19 | Cholesteric liquid crystal composition, oriented film and multicolor reflective plate |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001323125A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004041881A1 (en) * | 2002-11-05 | 2004-05-21 | Daicel Chemical Industries, Ltd. | Polymeric compound for photoresist and resin composition for photoresist |
WO2004113404A1 (en) * | 2003-06-19 | 2004-12-29 | Daicel Chemical Industries, Ltd. | Polymerizable monomer, polymer compound, resin composition for photoresist and method for producing semiconductor |
WO2007050532A1 (en) * | 2005-10-25 | 2007-05-03 | 3M Innovative Properties Company | High clarity cholesteric liquid crystal films |
JP2008090230A (en) * | 2006-10-05 | 2008-04-17 | Fujifilm Corp | Optical film, and its manufacturing method and its manufacturing device |
CN107779204A (en) * | 2016-08-25 | 2018-03-09 | 三星显示有限公司 | Liquid-crystal composition and the liquid crystal display for including it |
-
2000
- 2000-05-19 JP JP2000147230A patent/JP2001323125A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004041881A1 (en) * | 2002-11-05 | 2004-05-21 | Daicel Chemical Industries, Ltd. | Polymeric compound for photoresist and resin composition for photoresist |
US7033726B2 (en) | 2002-11-05 | 2006-04-25 | Daicel Chemical Industries, Ltd. | Photoresist polymeric compound and photoresist resin composition |
WO2004113404A1 (en) * | 2003-06-19 | 2004-12-29 | Daicel Chemical Industries, Ltd. | Polymerizable monomer, polymer compound, resin composition for photoresist and method for producing semiconductor |
WO2007050532A1 (en) * | 2005-10-25 | 2007-05-03 | 3M Innovative Properties Company | High clarity cholesteric liquid crystal films |
US7439000B2 (en) | 2005-10-25 | 2008-10-21 | 3M Innovative Properties Company | High clarity cholesteric liquid crystal films |
JP2008090230A (en) * | 2006-10-05 | 2008-04-17 | Fujifilm Corp | Optical film, and its manufacturing method and its manufacturing device |
JP4687909B2 (en) * | 2006-10-05 | 2011-05-25 | 富士フイルム株式会社 | Optical film manufacturing method and apparatus |
CN107779204A (en) * | 2016-08-25 | 2018-03-09 | 三星显示有限公司 | Liquid-crystal composition and the liquid crystal display for including it |
CN107779204B (en) * | 2016-08-25 | 2022-11-15 | 三星显示有限公司 | Liquid crystal composition and liquid crystal display including the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2143710B1 (en) | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optically anisotropic material | |
JP5401822B2 (en) | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body | |
EP2261201B1 (en) | Trifunctional (meth)acrylate compound and polymerizable composition containing the compound | |
JP5522047B2 (en) | Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystalline polymer and optical anisotropic body | |
JP2010270108A (en) | Compound | |
JPH11130729A (en) | Trifunctional compound and high molecular liquid crystal | |
JP5621584B2 (en) | Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystalline polymer and optical anisotropic body | |
JP4136193B2 (en) | Liquid crystal polymer composition, retardation plate and elliptically polarizing plate | |
JP2001323266A (en) | Cholesteric liquid crystal composition, oriented film and multicolor reflecting plate | |
EP2325168A1 (en) | Polymerizable optically active imide compound and polymerizable composition containing the compound | |
KR20110033773A (en) | Polymerizable compound | |
JP2003055661A (en) | Polymerizable liquid crystal composition and optically anisotropic body using the same | |
EP0980868A1 (en) | Optically active monomer, liquid crystalline polymer, and optical element | |
KR20100086922A (en) | Polymerizable biphenyl compound | |
JP4247861B2 (en) | Cholesteric liquid crystal composition, alignment film and multicolor reflector | |
JP2001323125A (en) | Cholesteric liquid crystal composition, oriented film and multicolor reflective plate | |
JP2000336362A (en) | Liquid crystal polymer composition, oriented film, and production of the same film | |
JP4208168B2 (en) | Cholesteric liquid crystal composition, alignment film and multicolor reflector | |
JP4266262B2 (en) | Cholesteric liquid crystal composition, alignment film and multicolor reflector | |
JP4441028B2 (en) | Oriented film and multicolor reflector | |
JP2003313250A (en) | Polymerizable liquid crystal composition and optical anisotropic body | |
JPH10158268A (en) | Optically active monomer, liquid crystal polymer and optical element | |
JP2000327720A (en) | Side chain type liquid crystal polymer, phase difference plate and oval polarizing plate | |
JP2000144132A (en) | Liquid crystal composition, optical element and its production, and optical member | |
JP2000144133A (en) | Nematic type liquid crystal composition, optical element and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061221 |